Blepharospasm disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: BLP003 MIFTS: 44	Blepharospasm Categories: Eye diseases, Genetic diseases, Neuronal diseases, Oral diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs Collapse all tables

Sources

Aliases & Classifications for Blepharospasm

MalaCards integrated aliases for Blepharospasm:

Name: Blepharospasm ¹² ⁷⁴ ⁵³ ²⁹ ⁵⁴ ⁶ ¹⁵ ³⁹ ⁷¹ ³²

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases
Anatomical: Neuronal diseases Eye diseases Oral diseases

See all MalaCards categories (disease lists)

ICD10: ³²

Diseases of the nervous system

Extrapyramidal and movement disorders

Dystonia

Blepharospasm

External Ids:

Disease Ontology ¹² DOID:529

ICD9CM ³⁴ 333.81

MeSH ⁴³ D001764 {http

NCIt ⁴⁹ C118723

SNOMED-CT ⁶⁷ 59026006

ICD10 ³² G24.5

UMLS ⁷¹ C0005747

Sources

Summaries for Blepharospasm

NINDS : ⁵³ Benign essential blepharospasm (BEB) is a progressive neurological disorder characterized by involuntary muscle contractions and spasms of the eyelid muscles. It is a form of dystonia, a movement disorder in which muscle contractions cause sustained eyelid closure, twitching or repetitive movements. BEB begins gradually with increased frequency of eye blinking often associated with eye irritation. Other symptoms may include increasing difficulty in keeping the eyes open, and light sensitivity. Generally, the spasms occur during the day, disappear in sleep, and reappear after waking. As the condition progresses, the spasms may intensify, forcing the eyelids to remain closed for long periods of time, and thereby causing substantial visual disturbance or functional blindness. It is important to note that the blindness is caused solely by the uncontrollable closing of the eyelids and not by a dysfunction of the eyes. BEB occurs in both men and women, although it is especially common in middle-aged and elderly women.

MalaCards based summary : Blepharospasm is related to lymphatic malformation 5 and dystonia 3, torsion, x-linked, and has symptoms including myoclonus, torticollis and oromandibular dystonia. An important gene associated with Blepharospasm is DRD5 (Dopamine Receptor D5). The drugs Acetylcholine and Silicon have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and cortex, and related phenotype is behavior/neurological.

Disease Ontology : ¹² A focal dystonia that is characterized by the involuntary, forcible contraction of the muscles controlling eye blinks.

Wikipedia : ⁷⁴ Blepharospasm is any abnormal contraction or twitch of the eyelid. The condition should be distinguished... more...

Sources

Related Diseases for Blepharospasm

Diseases in the Blepharospasm family:

Blepharospasm, Benign Essential

Diseases related to Blepharospasm via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 213, show less)

#	Related Disease	Score	Top Affiliating Genes
1	lymphatic malformation 5	33.3	TOR1A THAP1 SGCE OMD GCH1
2	dystonia 3, torsion, x-linked	31.1	TOR1A THAP1 SGCE GCH1 ATP1A3
3	torticollis	31.1	TOR1A CIZ1
4	spasmodic dysphonia	30.4	TOR1A THAP1
5	dystonia 24	30.1	THAP1 GNAL ANO3
6	bruxism	30.0	OMD KANTR DRD5
7	basal ganglia disease	30.0	TOR1A THAP1 GCH1
8	lingual-facial-buccal dyskinesia	29.9	OMD JRK DRD5
9	isolated dystonia	29.8	TOR1A THAP1 GNAL GCH1 ANO3
10	choreatic disease	29.7	SGCE JRK GCH1 DRD5
11	oromandibular dystonia	29.4	TOR1A THAP1 SGCE OMD GCH1 CIZ1
12	migraine with or without aura 1	29.4	SNAP25 NSF DRD5 ATP1A3
13	cranio-facial dystonia	29.1	TOR1A THAP1 SGCE GCH1 CDIP1
14	dystonia	28.9	TOR2A TOR1A TIMM8A THAP1 SGCE GNAL
15	dystonia 1, torsion, autosomal dominant	28.9	TOR2A TOR1A THAP1 SGCE GNAL GCH1
16	segmental dystonia	28.3	TOR1A THAP1 SGCE GNAL GCH1 CIZ1
17	movement disease	28.2	TOR1A THAP1 SGCE SERPINA3 OMD JRK
18	hemidystonia	28.1	TOR1A THAP1 SGCE JRK GNAL GCH1
19	dystonia 12	28.0	TOR1A THAP1 SGCE GNAL GCH1 CIZ1
20	multifocal dystonia	27.7	TOR1A THAP1 SGCE JRK GNAL GCH1
21	cervical dystonia	27.2	TOR1A THAP1 SNAP25 SGCE OMD JRK
22	focal dystonia	26.8	TOR1A TIMM8A THAP1 SNAP25 SGCE OMD
23	blepharospasm, benign essential	12.9
24	schwartz-jampel syndrome, type 1	11.5
25	aceruloplasminemia	11.5
26	spinocerebellar ataxia 31	11.5
27	dyt-thap1	11.5
28	corneal dystrophy, meesmann, 1	11.2
29	glaucoma 3, primary congenital, a	11.2
30	vernal keratoconjunctivitis	11.2
31	hemifacial spasm, familial	10.9
32	hemifacial spasm	10.9
33	ptosis	10.8
34	apraxia	10.6
35	apraxia of eyelid opening	10.5
36	yemenite deaf-blind hypopigmentation syndrome	10.5
37	tremor	10.4
38	cerebellopontine angle tumor	10.3	OMD KANTR
39	strabismus	10.3
40	mechanical strabismus	10.3
41	dystonia, focal, task-specific	10.3
42	supranuclear palsy, progressive, 1	10.3
43	bell's palsy	10.3
44	myasthenia gravis	10.3
45	lagophthalmos	10.3
46	eye disease	10.3
47	keratitis, hereditary	10.2
48	ataxia and polyneuropathy, adult-onset	10.2
49	facial paralysis	10.2
50	dystonia 6, torsion	10.2	THAP1 CIZ1
51	dystonia 23	10.2	CIZ1 ANO3
52	tardive dyskinesia	10.2
53	headache	10.2
54	myoclonus	10.2
55	spastic monoplegia	10.2	TOR1A JRK
56	torsion dystonia 4	10.2	GNAL CIZ1 ANO3
57	dystonia 27	10.1	GNAL CIZ1 ANO3
58	alternating esotropia	10.1	KANTR JRK
59	facial spasm	10.1
60	multiple system atrophy 1	10.1
61	obsessive-compulsive disorder	10.1
62	dry eye syndrome	10.1
63	ectropion	10.1
64	tic disorder	10.1
65	leber optic atrophy and dystonia	10.1	THAP1 SGCE GCH1
66	parkinson disease, late-onset	10.1
67	intraocular pressure quantitative trait locus	10.1
68	paranoid schizophrenia	10.1
69	entropion	10.1
70	keratoconjunctivitis	10.1
71	exposure keratitis	10.1
72	dysphagia	10.1
73	encephalopathy	10.1
74	spasticity	10.1
75	purine-pyrimidine metabolic disorder	10.0	THAP1 GCH1
76	autoimmune disease	10.0
77	systemic lupus erythematosus	10.0
78	3-methylglutaconic aciduria, type iii	10.0
79	thymoma, familial	10.0
80	astigmatism	10.0
81	chorea, childhood-onset, with psychomotor retardation	10.0
82	sexual disorder	10.0
83	scoliosis	10.0
84	blepharophimosis	10.0
85	hydrocephalus	10.0
86	generalized anxiety disorder	10.0
87	autosomal dominant cerebellar ataxia	10.0
88	keratopathy	10.0
89	kernicterus	10.0
90	thymoma	10.0
91	mood disorder	10.0
92	essential tremor	10.0
93	sleep disorder	10.0
94	encephalitis	10.0
95	pathologic nystagmus	10.0
96	cluster headache	10.0
97	depression	10.0
98	myotonia	10.0
99	wound botulism	10.0	SNAP25 NSF
100	infant botulism	10.0	SNAP25 NSF
101	specific developmental disorder	9.9	SNAP25 SERPINA3 DRD5
102	oculogyric crisis	9.9	GCH1 DRD5 ATP1A3
103	torsion dystonia 2	9.9	TOR1A THAP1 GNAL CIZ1 ANO3
104	dystonia 25	9.9	TOR1A THAP1 GNAL CIZ1 ANO3
105	hereditary dystonia	9.9	GCH1 ATP1A3 ANO3
106	hereditary lymphedema ii	9.9	TOR1A THAP1 SGCE OMD GCH1
107	breast cancer	9.8
108	glaucoma, primary open angle	9.8
109	hand skill, relative	9.8
110	neurofibromatosis, type i	9.8
111	polykaryocytosis inducer	9.8
112	trigeminal neuralgia	9.8
113	zinc finger protein 1	9.8
114	cerebrotendinous xanthomatosis	9.8
115	parkinson disease 15, autosomal recessive early-onset	9.8
116	wilson disease	9.8
117	mohr-tranebjaerg syndrome	9.8
118	kearns-sayre syndrome	9.8
119	chromosome 18q deletion syndrome	9.8
120	dystonia 7, torsion	9.8
121	xanthomatosis	9.8
122	branchiootic syndrome 1	9.8
123	meningioma, radiation-induced	9.8
124	meningioma, familial	9.8
125	dystonia 13, torsion, autosomal dominant	9.8
126	anxiety	9.8
127	major depressive disorder	9.8
128	dystonia 16	9.8
129	striatal degeneration, autosomal dominant 2	9.8
130	angiosarcoma	9.8
131	vitamin b12 deficiency	9.8
132	autosomal recessive disease	9.8
133	aphasia	9.8
134	stuttering	9.8
135	cardiac arrest	9.8
136	cysticercosis	9.8
137	suppression amblyopia	9.8
138	amblyopia	9.8
139	open-angle glaucoma	9.8
140	paralytic squint	9.8
141	hemiplegia	9.8
142	prostatic hypertrophy	9.8
143	enophthalmos	9.8
144	schizophreniform disorder	9.8
145	tetanus	9.8
146	lens subluxation	9.8
147	spinal meningioma	9.8
148	fuchs' endothelial dystrophy	9.8
149	mononeuropathy	9.8
150	dysthymic disorder	9.8
151	spastic entropion	9.8
152	telangiectasis	9.8
153	hypochondriasis	9.8
154	keratoconjunctivitis sicca	9.8
155	acute closed-angle glaucoma	9.8
156	olivopontocerebellar atrophy	9.8
157	communicating hydrocephalus	9.8
158	mental depression	9.8
159	optic nerve disease	9.8
160	hyperuricemia	9.8
161	bardet-biedl syndrome	9.8
162	papillary carcinoma	9.8
163	complex regional pain syndrome	9.8
164	pseudohypoparathyroidism	9.8
165	brain stem glioma	9.8
166	secretory meningioma	9.8
167	lymphoplasmacyte-rich meningioma	9.8
168	benign ependymoma	9.8
169	ganglioglioma	9.8
170	eyelid disease	9.8
171	schizoaffective disorder	9.8
172	cellular ependymoma	9.8
173	conjunctivitis	9.8
174	severe combined immunodeficiency	9.8
175	cerebellopontine angle meningioma	9.8
176	adenoma	9.8
177	parathyroid adenoma	9.8
178	cataract	9.8
179	retinal degeneration	9.8
180	herpes zoster	9.8
181	neurofibromatosis	9.8
182	lupus erythematosus	9.8
183	rosacea	9.8
184	narcolepsy	9.8
185	speech disorder	9.8
186	blepharitis	9.8
187	episodic ataxia	9.8
188	48,xyyy	9.8
189	corticobasal degeneration	9.8
190	glioma	9.8
191	orbital varix	9.8
192	tuberculous meningitis	9.8
193	weber syndrome	9.8
194	anoxia	9.8
195	chronic pain	9.8
196	hypertonia	9.8
197	postherpetic neuralgia	9.8
198	psychogenic movement	9.8
199	swallowing disorders	9.8
200	posttransplant acute limbic encephalitis	9.8
201	glial tumor	9.8
202	bickerstaff brainstem encephalitis	9.8
203	multiple system atrophy, parkinsonian type	9.8
204	thyroid carcinoma	9.8
205	infancy electroclinical syndrome	9.8	SNAP25 KANTR
206	neurodegeneration with brain iron accumulation	9.7	TOR1A THAP1 GCH1 ATP1A3
207	dystonia, dopa-responsive	9.6	TOR1A THAP1 SGCE GCH1 ATP1A3
208	leber plus disease	9.5	SGCE SERPINA3 JRK GCH1
209	focal hand dystonia	9.4	TOR1A THAP1 SGCE JRK GNAL GCH1
210	benign familial infantile epilepsy	9.3	THAP1 SNAP25 GNAL CIZ1 ATP1A3 ANO3
211	alternating hemiplegia of childhood	9.1	THAP1 SGCE GNAL GCH1 CIZ1 ATP1A3
212	dystonia 11, myoclonic	8.9	TOR1A THAP1 SGCE JRK GNAL GCH1
213	spasmodic dystonia	8.5	TOR1A THAP1 SGCE OMD JRK GNAL

Graphical network of the top 20 diseases related to Blepharospasm:

Sources

Symptoms & Phenotypes for Blepharospasm

UMLS symptoms related to Blepharospasm:

myoclonus, torticollis, oromandibular dystonia, lingual dystonia, erythema of the eyelids, spasmodic torticollis

MGI Mouse Phenotypes related to Blepharospasm:

⁴⁵ (showing 1, show less)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.47	ARSG ATP1A3 CDIP1 CIZ1 DRD5 GNAL

Sources

Drugs & Therapeutics for Blepharospasm

Drugs for Blepharospasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 42, show less)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Acetylcholine

Approved, Investigational

Phase 4

51-84-3

187

Silicon

Approved, Investigational

Phase 4

7440-21-3

4082203

incobotulinumtoxinA

Phase 4

abobotulinumtoxinA

Phase 4

Botulinum Toxins, Type A

Phase 4

Cholinergic Agents

Phase 4

Botulinum Toxins

Phase 4

Neurotransmitter Agents

Phase 4

rimabotulinumtoxinB

Phase 4

Pharmaceutical Solutions

Phase 3

Anticonvulsants

Phase 2, Phase 3

Epidiolex

Phase 2, Phase 3

Etanercept

Approved, Investigational

Phase 1, Phase 2

185243-69-0

Mexiletine

Approved, Investigational

Phase 2

31828-71-4

4178

Anti-Inflammatory Agents

Phase 1, Phase 2

Analgesics, Non-Narcotic

Phase 1, Phase 2

Gastrointestinal Agents

Phase 1, Phase 2

Immunologic Factors

Phase 1, Phase 2

Analgesics

Phase 1, Phase 2

Immunosuppressive Agents

Phase 1, Phase 2

Autoantibodies

Phase 1, Phase 2

Antirheumatic Agents

Phase 1, Phase 2

Anti-Inflammatory Agents, Non-Steroidal

Phase 1, Phase 2

Sodium Channel Blockers

Phase 2

Anti-Arrhythmia Agents

Phase 2

Diuretics, Potassium Sparing

Phase 2

Zinc

Approved, Investigational

7440-66-6

32051

Carbamazepine

Approved, Investigational

298-46-4

2554

Methylprednisolone

Approved, Vet_approved

83-43-2

6741

Methylprednisolone hemisuccinate

Approved

2921-57-5

Prednisolone phosphate

Approved, Vet_approved

302-25-0

Prednisolone

Approved, Vet_approved

50-24-8

5755

Prednisolone acetate

Approved, Vet_approved

52-21-1

Prednisolone hemisuccinate

Experimental

2920-86-7

Cortisone

Experimental

53-06-5

222786

Zinc Supplement

Ophthalmic Solutions

Dihydroxyphenylalanine

Methylprednisolone Acetate

Anesthetics

Anesthetics, Local

Lidocaine, Prilocaine Drug Combination

Interventional clinical trials:

(showing 63, show less)

#	Name	Status	NCT ID	Phase	Drugs
1	DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL OF THE SAFETY AND EFFICACY OF BOTULINUM TOXIN TYPE A (BOTOX) IN BRUXISM	Unknown status	NCT00908050	Phase 4	Botulinum toxin type A
2	An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids	Unknown status	NCT01583478	Phase 4
3	The Impact of Botulinum Toxin Injection in the Frontalis on Brow Height and Morphology: A Randomized Trial	Unknown status	NCT03186001	Phase 4	Abobotulinum toxin A
4	Multi-center, Phase Ⅳ, Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Meditoxin® in Subjects With Essential Blepharospasm	Completed	NCT01259557	Phase 4	Botulinum Toxin Type A
5	Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm	Completed	NCT00761592	Phase 4
6	Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm	Completed	NCT03641950	Phase 4	Botulinum toxin type A
7	Randomized, Double Blind, Active Controlled Study of the Efficacy, Surgical Outcome and Complications of Silicone Rod Sling in Frontalis Sling Suspension Surgery	Completed	NCT00753831	Phase 4
8	Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm: a Randomized, Triple-blind, Placebo-controlled, Cross-over Clinical Trial	Completed	NCT03508882	Phase 4	Botulinum Toxin Type A 100Unit/Vial (Product);Saline Solution for Injection
9	Measuring the Functional Effects of Botox on the Brain Using MR Spectroscopy and fMRI	Completed	NCT03373162	Phase 4	onabotulinumtoxinA
10	An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®).	Completed	NCT00208091	Phase 4	Botulinum toxin, type B
11	A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of "Crow's Feet."	Completed	NCT01529788	Phase 4	Right lateral orbital injection of Botox Cosmetic or Dysport;Left lateral orbital injection of Botox Cosmetic or Dysport
12	Comparison of Efficacy of 250 Units Versus 500 Units of Botulinum Toxin in the Treatment of Refractory Vaginismus	Unknown status	NCT00638066	Phase 3	botulinum toxin;botulinum toxin A
13	A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase II/III Clinical Trial to Compare the Safety and Efficacy of NABOTA Versus BOTOX in Treatment of Essential Blepharospasm	Completed	NCT02947815	Phase 2, Phase 3	Clostridium Botulinum Toxin Type A;Clostridium Botulinum Toxin Type A
14	A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients With Essential Blepharospasm	Completed	NCT03216473	Phase 3	Neuronox;Botox
15	Double-blinded, Randomized, Active Control Comparative, Parallel-designed, Phase III Clinical Trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." In Essential Blepharospasm Running Parallel With Phase I Study	Completed	NCT01791881	Phase 3	Hugeltox;Botulinum Toxin Type A(Botox®)
16	Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With an Open-label Extension Period to Investigate the Efficacy and Safety of incobotulinumtoxinA (Xeomin) in the Treatment of Blepharospasm	Completed	NCT00406367	Phase 3	incobotulinumtoxinA (Xeomin);Placebo
17	Prospective, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of Two Different Doses of NT 201 in Botulinum Toxin Treatment-naïve Subjects With Blepharospasm	Completed	NCT01896895	Phase 3	IncobulinumtoxinA (Xeomin), 25 Units;IncobotulinumtoxinA (Xeomin), 12.5 Units;Placebo;IncobotulinumtoxinA (Xeomin), 35 Units
18	Double-Blind, Randomized, Phase 3, Comparative Study of a New Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm	Completed	NCT00682760	Phase 3	Korean Botulinum toxin type A (KbtxA) and Botox injection
19	Efficacy and Safety of Xeomin for the Treatment of Notalgia Paresthetica	Completed	NCT01098019	Phase 3	Xeomin;Placebo / Xeomin
20	Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study	Completed	NCT02604186	Phase 2, Phase 3
21	Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study	Recruiting	NCT02555982	Phase 3	BOTOX ® 200 Unités;Placebo
22	Use of Botulinum Toxin (BTX) for the Treatment of Peripheral Painful Traumatic Trigeminal Neuropathy (PPTTN)	Recruiting	NCT03555916	Phase 3	BOTOX®, Allergan;Placebo
23	Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - a Prospective Double-masked Cross-over Study	Enrolling by invitation	NCT04423341	Phase 2, Phase 3	Cannabidiol Oral Solution [Epidiolex]
24	A 48-Week Prospective, Double-Blinded, Randomized, Cross-over Design in Multicenter Study of 250 Unit of Dysport Versus 50 Unit of Neuronox Injection For Cervical Dystonia in Thai Patients	Enrolling by invitation	NCT03805152	Phase 3	Neuronox(R);Dysport (R)
25	ASIS for Enbrel in Plaque Psoriasis	Unknown status	NCT02112097	Phase 1, Phase 2	Gadolinium;Gadolinium;Gadolinium;Efficacy of Enbrel subcutaneously at Week 12;Efficacy of Enbrel subcutaneously at Week 24;Efficacy of Enbrel subcutaneously at Week 36;Efficacy of Enbrel subdermally at Week 12;Efficacy of Enbrel subdermally at Week 24;Efficacy of Enbrel subdermally at Week 36;PASI 75 n(%) subcutaneously at Week 12;PASI 75 n(%) subcutaneously at Week 24;PASI 75 n(%) subcutaneously at Week 36;PASI 75 n(%) subdermally at Week 12;PASI 75 n(%) subdermally at Week 24;PASI 75 n(%) subdermally at Week 36;Adverse Reactions of Enbrel subcutaneously;Adverse Reactions of Enbrel subdermally at Week 36;Gadolinium;Gadolinium;Gadolinium
26	Phase II, Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection, of Three Doses of Dysport (40 Units/Eye, 80 Units/Eye, and 120 Units/Eye) for the Treatment of Benign Essential Blepharospasm	Completed	NCT00234507	Phase 2
27	A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm	Completed	NCT00942851	Phase 1, Phase 2	Acetyl-Hexapeptide Topical Treatment;placebo
28	Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.	Completed	NCT00411255	Phase 2
29	Mexiletine for the Treatment of Focal Dystonia	Completed	NCT00001784	Phase 2	Mexiletine
30	Prospective, Open-label, Single-arm, Single-center Trial to Investigate the Tolerability of NT 201 and Quality of Life of Patients in the Treatment of Blepharospasm With Shortened Injection Intervals	Terminated	NCT00507637	Phase 2	NT 201
31	Placebo Controlled Double Blind Study of Acetyl Hexapeptide-8 in Treatment of Blepharospasm	Terminated	NCT01750346	Phase 2	Topical acetyl hexapeptide-8;Placebo
32	Effect of Two Different Surgical Methods on the Prognosis of Patients With Blepharospasm	Unknown status	NCT02765113	Early Phase 1
33	Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm	Unknown status	NCT02327728		Botulinum toxin A 12.5U;Botulinum toxin A 10U
34	The Effect of Zinc Supplementation on the Efficacy and Duration of Botulinum Toxin for the Treatment of Oculofacial Spasm Disorders	Unknown status	NCT01546805		Zinc Supplement;Sugar pill
35	A Randomised Controlled Trial to Explore the Effectiveness and Cost-effectiveness of a Patient-initiated Botulinum Toxin Treatment Model for Blepharospasm and Hemifacial Spasm Compared to Treatment as Usual	Unknown status	NCT02577224
36	The Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm- a Pilot Study.	Unknown status	NCT01759745
37	Blepharospasm Patient Survey: A Structured Interview Evaluating Previous and Current incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA Treatment for Patients With Blepharospasm	Completed	NCT01686061
38	A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm	Completed	NCT02245958
39	A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm	Completed	NCT01814774
40	MDs on Botox Utility (MOBILITY)	Completed	NCT00535938
41	A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR)	Completed	NCT00210431
42	Diagnostic and Rating Tools for Blepharospasm	Completed	NCT02780336
43	Movement Disorder Survey in East China	Completed	NCT01168388
44	Combined Effects of rTMS and Botulinum Toxin in Benign Essential Blepharospasm: A Novel Approach	Completed	NCT02370875
45	Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States	Completed	NCT01287247
46	Role of the Cortical Medial Frontal Areas in Blepharospasm	Completed	NCT00500799
47	Clinical Trial of a Mechanical Device for the Treatment of Blepharospasm	Completed	NCT03269123
48	Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Patients With Dystonia	Completed	NCT00773604
49	Botulinum Toxin in the Treatment of Raynaud's	Completed	NCT01233999		botulinum toxin A
50	Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia	Completed	NCT01761903
51	Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives	Completed	NCT00082615
52	Efficacy of Botulinum Toxin A Intradetrusor Injections for the Treatment of Non-neurogenic Urinary Urge Incontinence- A Randomized Double-Blind Control Trial	Completed	NCT01226706		Botulinum Toxins, Type A;Placebos
53	The Role of the Upper Colliculus in the Idiopathic Blepharospasm : a Pilot Study in Functional MRI	Recruiting	NCT03903341
54	Effect of Lipid Based Eye Drops on Tear Film Lipid Layer Thickness in Subjects With Dry Eye Disease, Meibomian Gland Dysfunction, Blepharospasm and Healthy Subjects - a Pilot Study	Recruiting	NCT03399292		Cationorm MD sine eye drops
55	Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia	Recruiting	NCT01373424
56	Analyse de la Marche de Patients Atteints de Dystonie Focale Avant et après Traitement Par Toxine Botulique	Recruiting	NCT03938363		Botulinum Toxin injection
57	HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions: a Multicenter Clinical Study	Recruiting	NCT03184597
58	Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis: a Randomized Controlled Study	Recruiting	NCT02196155		Botulinum toxin A;cortisone;Saline
59	Jitter's Recording in a Spastic Muscle Treated by Botulinum Toxin	Recruiting	NCT04002843
60	Biomarker for Cystinosis Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL	Active, not recruiting	NCT02837523
61	Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients With Dystonia and Healthy Controls	Terminated	NCT00487383
62	Study of the Photic Blink Reflex in Patients With Blepharospasm and Increased Blinking	Terminated	NCT03263000
63	Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia	Terminated	NCT04156022

Search NIH Clinical Center for Blepharospasm

Inferred drug relations via UMLS ⁷¹ / NDF-RT ⁵⁰ :

Botulinum Toxin Type A

Cyproheptadine

Cyproheptadine hydrochloride

CYPROHEPTADINE HYDROCHLORIDE MONOHYDRATE

Sources

Genetic Tests for Blepharospasm

Genetic tests related to Blepharospasm:

#	Genetic test	Affiliating Genes
1	Blepharospasm ²⁹	DRD5

Sources

Anatomical Context for Blepharospasm

MalaCards organs/tissues related to Blepharospasm:

⁴⁰

Eye, Brain, Cortex, Skin, Cerebellum, Testes, Subthalamic Nucleus

Sources

Publications for Blepharospasm

Articles related to Blepharospasm:

(showing 1817, show less)

#	Title	Authors	PMID	Year
1	The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm. ⁵⁴ ⁶¹	Defazio G...Berardelli A	19202559	2009
2	Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm. ⁶¹ ⁵⁴	Clarimon J...Singleton AB	17133500	2007
3	A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm. ⁶¹ ⁵⁴	Misbahuddin A...Warner TT	11781417	2002
4	The first UK national blepharospasm patient and public involvement day; identifying priorities. ⁶¹	Murta FR...Ezra DG	31466502	2020
5	Does EMG provide essential information for the diagnosis and treatment of blepharospasm? ⁶¹	Conte A...Berardelli A	32387048	2020
6	Pretarsal blepharospasm: Clinical and electromyographic characteristics. ⁶¹	Grandas F...Esteban A	32280019	2020
7	Use of free oral mucosal graft for treatment of feline eyelid agenesis in seven patients. ⁶¹	Warren C...Reinstein S	32524714	2020
8	Blepharospasm, dry eye and extractable nuclear antigen antibodies. ⁶¹	Girard BC...Levy P	32532571	2020
9	Serum calcium, magnesium, phosphorus, and vitamin D in benign essential blepharospasm. ⁶¹	Serefoglu Cabuk K...Taskapili M	32236706	2020
10	CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm. ⁶¹	Siokas V...Dardiotis E	32424513	2020
11	The good toxin: 10 years of experience with botulinum toxin A in the treatment of benign essential blepharospasm. ⁶¹	Lai KK...Ko ST	32544987	2020
12	Patient-reported responses to medical treatment in primary dystonia. ⁶¹	Woo KA...Jeon B	32249176	2020
13	Blepharospasm With Photophobia Secondary to Midbrain Tuberculoma and Thalamic Infarct. ⁶¹	Chouksey A...Pandey S	32358466	2020
14	FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. ⁶¹	Spiegel LL...Bledsoe IO	32429600	2020
15	Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy. ⁶¹	Walter U...Kamm C	32332130	2020
16	Evaluation of partial tarsal plate excision using a transconjunctival approach for the treatment of distichiasis in dogs. ⁶¹	Palella Gomez A...Pinheiro de Lacerda R	32083378	2020
17	Clinical Rating Scales and Quantitative Assessments of Movement Disorders. ⁶¹	Tarakad A	32279708	2020
18	Comment on: A trial of a mechanical device for the treatment of blepharospasm. ⁶¹	Go JA...Lee AG	31586170	2020
19	Psychiatric disorders in blepharospasm: A 10-year follow-up study. ⁶¹	Berardelli I...Fabbrini G	32505028	2020
20	Analgesic effect of topical and subconjunctival morphine in dogs after phacoemulsification: A pilot study. ⁶¹	Spertus CB...Ledbetter EC	32369267	2020
21	An objective tool to measure the effect of botulinum toxin in blepharospasm and hemifacial spasm. ⁶¹	Osaki MH...Cruz AAV	32294304	2020
22	Ophthalmology. ⁶¹	Wan MJ...Hunter DG	32270340	2020
23	Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins. ⁶¹	Hassell TJW...Charles D	32331272	2020
24	Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias. ⁶¹	De Bartolo MI...Conte A	32344856	2020
25	Apraxia of eyelid opening secondary to possible progressive supranuclear palsy: a case report. ⁶¹	Jiang W...Yu P	32299276	2020
26	Abnormal Neural Responses During Reflexive Blinking in Blepharospasm: An Event-Related Functional MRI Study. ⁶¹	Nguyen P...Berman BD	32250472	2020
27	Personality traits associated with blepharospasm: A comparison with healthy subjects, patients with facial hemispasm and patients with hyperhidrosis. ⁶¹	Santangelo G...Esposito M	32067829	2020
28	Chorea and Parkinsonism with Elevated Striational Antibody. ⁶¹	Gupta HV...Jassam Y	32189867	2020
29	Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study. ⁶¹	Berman BD...Perlmutter JS	31848221	2020
30	Polytetrafluoroethylene frontalis suspension in blepharospasm with eyelid apraxia: an effective and well-tolerated adjunct to botulinum toxin therapy. ⁶¹	Sweeney AR...Yen MT	32172614	2020
31	Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm? ⁶¹	Lawes-Wickwar S...Ezra DG	32116098	2020
32	Surgical management of bilateral, upper and lower eyelid entropion in 27 Shar Pei dogs, using the Stades forced granulation procedure of the upper eyelid only. ⁶¹	Asti M...Barsotti G	31738860	2020
33	Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China. ⁶¹	Fang XB...Zhang WX	31745757	2020
34	Personality profile of the primary blepharospasm (BSP): An investigation using the Minnesota Multiphasic Personality Inventory. ⁶¹	Liu X...Liu P	32035164	2020
35	Does the network model fits neurophysiological abnormalities in blepharospasm? ⁶¹	Mascia MM...Defazio G	32215851	2020
36	Association between cannabis and the eyelids: A comprehensive review. ⁶¹	Nguyen AX...Wu AY	31747112	2020
37	Flanker Task Performance in Isolated Dystonia (Blepharospasm): A Focus on Sequential Effects. ⁶¹	Pekrul M...Kopp B	32024200	2020
38	Blepharospasm as the presenting feature of papillary thyroid cancer and parathyroid adenoma. ⁶¹	Jamora RDG...Cuanang JR	31889644	2020
39	Sex, blinking, and dry eye. ⁶¹	Culoso A...Evinger C	31940243	2020
40	Soft Nanomembrane Sensors and Flexible Hybrid Bioelectronics for Wireless Quantification of Blepharospasm. ⁶¹	Mahmood M...Yeo WH	32091988	2020
41	Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment. ⁶¹	Hosotani Y...Gomi F	31823132	2020
42	Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin. ⁶¹	Lai HT...Lai CS	31833891	2020
43	Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin. ⁶¹	Teive HAG...Camargo CHF	31967203	2020
44	Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin. ⁶¹	Teive HAG...Camargo CHF	32074181	2020
45	Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice. ⁶¹	Jochim A...Haslinger B	31630241	2020
46	Clinical, ultrasonographic, and histopathologic findings in seven horses with Descemet's membrane detachment: A case series. ⁶¹	Slenter IJM...Boeve MH	31544302	2020
47	Quality of life in idiopathic dystonia: a systematic review. ⁶¹	Girach A...Zis P	30460447	2019
48	Dry eye syndrome in benign essential blepharospasm. ⁶¹	Girard BC...Levy P	31733914	2019
49	Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis. ⁶¹	Peeters F...Casteels I	31560113	2019
50	Meibomian gland inversion: under-recognized entity. ⁶¹	Siah WF...Malhotra R	31184427	2019
51	Dystonia and Parkinson's disease: What is the relationship? ⁶¹	Shetty AS...Lang AE	31078682	2019
52	Sensory Tricks in Pantothenate Kinase-Associated Neurodegeneration: Video-Analysis of 43 Patients. ⁶¹	Martins J...Temudo T	31745482	2019
53	Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm. ⁶¹	Vivancos-Matellano F...Mascias-Cadavid J	31741669	2019
54	A trial of a mechanical device for the treatment of blepharospasm. ⁶¹	Fantato A...Elston J	31267089	2019
55	The use of autologous serum eye drops for the treatment of ocular surface disorders. ⁶¹	Garcia-Martin E...Sanjurjo-Saez M	31798853	2019
56	Deep brain stimulation for Meige syndrome: a meta-analysis with individual patient data. ⁶¹	Wang X...Yu X	31302747	2019
57	Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study. ⁶¹	Wein T...Trentin G	31256770	2019
58	Ocular motor manifestations of movement disorders. ⁶¹	Crotty GF...Chwalisz BK	31449085	2019
59	Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications. ⁶¹	Ferrazzano G...Berardelli A	31359200	2019
60	Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study. ⁶¹	Sane S...Naik MN	31612653	2019
61	Effect of light on blinking in patients with idiopathic isolated blepharospasm. ⁶¹	Wu Y...Hallett M	31621610	2019
62	Latrodectus Facies After Latrodectus Hesperus Envenomation in a Pediatric Patient. ⁶¹	Halmo LS...Wang GS	31492593	2019
63	Remission in dystonia - Systematic review of the literature and meta-analysis. ⁶¹	Mainka T...Ganos C	30898428	2019
64	Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm. ⁶¹	Sacramento DRC...Cardoso F	31251420	2019
65	A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time. ⁶¹	Trotta GF...Bevilacqua V	31386970	2019
66	Cognitive correlates of prospective memory in dystonia. ⁶¹	Maggi G...Santangelo G	31279634	2019
67	What is the evidence for cannabis use in otolaryngology?: A narrative review. ⁶¹	Valentino WL...McKinnon BJ	31174932	2019
68	Paroxysmal Dysarthria Ataxia-Tremor-Blepharospasm Syndrome in Bickerstaff Brainstem Encephalitis: A Variant of Paroxysmal Dysarthria Ataxia Syndrome. ⁶¹	Maramattom BV	31744988	2019
69	Unravelling mechanisms of altered modulation of trigemino-facial circuits in blepharospasm. ⁶¹	Baione V...Conte A	31326645	2019
70	Mini-incisional entropion repair for correcting involutional entropion: Full description and surgical outcome. ⁶¹	Han J...Shin HJ	31415368	2019
71	Pain in cervical dystonia: Evidence of abnormal inhibitory control. ⁶¹	Tinazzi M...Erro R	31227336	2019
72	The History of Botulinum Toxins in Medicine: A Thousand Year Journey. ⁶¹	Whitcup SM	31451970	2019
73	Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics. ⁶¹	Kunkler AL...Cebulla CM	31098752	2019
74	Abnormal spontaneous neural activity of brain regions in patients with primary blepharospasm at rest. ⁶¹	Jiang W...Luo S	31220741	2019
75	Blepharospasm: A genetic screening study in 132 patients. ⁶¹	Hammer M...Singleton A	30956059	2019
76	[Therapy of Benign Essential Blepharospasm with Botulinum Toxin]. ⁶¹	Kaltenmaier M...Maschke M	30970386	2019
77	Follicular choristoma in the third eyelid of an eclectus parrot (Eclectus roratus). ⁶¹	Darden JE...Scott EM	31194665	2019
78	A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism. ⁶¹	Westenberger A...Klein C	30973967	2019
79	Bilateral Anterior Uveitis in a Northern Saw-whet Owl (Aegolius acadicus) With a Metastatic Pectoral Malignant Mesenchymoma. ⁶¹	Henriksen ML...Willette M	31251505	2019
80	[Botulinumtoxin in Ophthalmology]. ⁶¹	Wabbels B	30999362	2019
81	Treatment Effects of Botulinum Toxin Injection and Acupuncture on Blepharospasm Assessed by the Change in Lower Eyelid Tension. ⁶¹	Bao FF...Xiang MH	30724635	2019
82	Impact of botulinum toxin injections on quality of life and self-esteem in patients with blepharospasm. ⁶¹	Tang M...Liu P	30463432	2019
83	Writing, reading, and speaking in blepharospasm. ⁶¹	Ferrazzano G...Fabbrini G	30783748	2019
84	An 8-Year-Old Girl with Blepharospasm and Left Thalamic Tumor. ⁶¹	Cavalheiro S...Stavale JN	31016833	2019
85	Predictive factors for long-term clinical outcomes of deep brain stimulation in the treatment of primary Meige syndrome. ⁶¹	Wang X...Yu X	30952124	2019
86	Advanced spheroidal degeneration. ⁶¹	Elhusseiny AM...Saad AA	32076391	2019
87	Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia. ⁶¹	Bladen JC...Malhotra R	30202071	2019
88	Primary angle-closure glaucoma with goniodysgenesis in a Beagle dog. ⁶¹	Park SA...Komaromy AM	30832652	2019
89	Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm. ⁶¹	Olson RM...Harrison AR	30380945	2019
90	Lack of Association of the rs11655081 ARSG Gene with Blepharospasm. ⁶¹	Siokas V...Dardiotis E	30656493	2019
91	BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm. ⁶¹	Siokas V...Dardiotis E	30519954	2019
92	Trans-1,1,1,4,4,4-hexafluoro-2-butene (HFO-1336mzz-E) (2018). ⁶¹		30862300	2019
93	The use of hyaluronic acid subdermal filler for entropion in canines and felines: 40 cases. ⁶¹	McDonald JE...Knollinger AM	29520917	2019
94	Use of botulinum toxin in Parkinson's disease. ⁶¹	Jocson A...Lew M	30579818	2019
95	Disease progression in blepharospasm: a 5-year longitudinal study. ⁶¹	Ferrazzano G...Fabbrini G	30308706	2019
96	High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy. ⁶¹	Albrecht P...Hefter H	30464031	2019
97	Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia. ⁶¹	Defazio G...Berardelli A	30269178	2019
98	The Prevalence and Correlation of Non-motor Symptoms in Adult Patients with Idiopathic Focal or Segmental Dystonia. ⁶¹	Novaretti N...Tumas V	30783550	2019
99	Sensory Trick Frames: A New Device for Blepharospasm Patients. ⁶¹	Lorenzano D...Ezra DG	30642155	2019
100	Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia. ⁶¹	Byun YS...Yang SW	31163059	2019
101	Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm. ⁶¹	Dong H...Peng B	32038460	2019
102	Orbital varix: rare cause of blepharospasm. ⁶¹	Hmida B...Golli M	31303918	2019
103	How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. ⁶¹	Phokaewvarangkul O...Bhidayasiri R	31333840	2019
104	Treatment of psychiatric disturbances in common hyperkinetic movement disorders. ⁶¹	Berardelli I...Fabbrini G	30501439	2019
105	Adult-Onset Gilles de la Tourette Syndrome: Psychogenic or Organic? The Challenge of Abnormal Neurophysiological Findings. ⁶¹	Versace V...Kofler M	31130912	2019
106	Dystonic tics in patients with Gilles de la Tourette syndrome. ⁶¹	Szejko N...Janik P	31621889	2019
107	Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation. ⁶¹	Gurbuz G...Albayrak HM	32134596	2019
108	Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. ⁶¹	Dong H...Peng B	30587995	2019
109	Structural brain network fingerprints of focal dystonia. ⁶¹	Chirumamilla VC...Groppa S	31798688	2019
110	Comparison Therapeutic Effects of Ciprofloxacin, Silver Nanoparticles and Their Combination in the Treatment of Pseudomonas keratitis in Rabbit: An Experimental Study. ⁶¹	Zavarshani M...Dalir Naghadeh B	31089366	2019
111	Effect of Botulinum toxin A application in neuro-ophtalmologic indications on Schirmers test and tears osmolarity. ⁶¹	Ziak P...Mojzis P	31537075	2019
112	Clinical experience with patients with spasmodic dysphonia and primary Meige syndrome. ⁶¹	Pedrero-Escalas MF...Gavilan J	29716720	2019
113	Rare Complication of Botox Injection: A Case Report. ⁶¹	Rouientan A...Tizmaghz A	30873373	2019
114	Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease. ⁶¹	Ramirez-Gomez CC...Micheli F	30649026	2019
115	Traumatic phacocele in an American Miniature Horse. ⁶¹	Knickelbein KE...Lassaline ME	29517148	2019
116	Glucose hypometabolism in the visual cortex proportional to disease severity in patients with essential blepharospasm. ⁶¹	Suzuki Y...Ishii K	31487599	2019
117	Orbital Rosai-Dorfman Disease: A Case Report and Literature Review. ⁶¹	Al-Maghrabi B...Al-Maghrabi J	31008056	2019
118	Use of equine amniotic membrane free-island grafts for treatment of a midstromal corneal ulcer and descemetocele in a snow leopard (Panthera uncia). ⁶¹	Knollinger AM...Crook EK	30668260	2018
119	Abnormal sensory gating in patients with different types of focal dystonias. ⁶¹	Conte A...Berardelli A	30403835	2018
120	Epidemiological and clinical aspects of a sample of Brazilian patients with primary dystonia and the impact of the new classification on their clinical evaluation. ⁶¹	Bezerra TC...Tumas V	30698205	2018
121	[Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain]. ⁶¹	Sanz-Granda A...Catalan MJ	30536360	2018
122	Acute intensive care unit management of mustard gas victims: the Turkish experience. ⁶¹	Kilic E...Kenar L	29648477	2018
123	Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia. ⁶¹	Esposito M...Defazio G	29935029	2018
124	Morphological and functional findings in Alström syndrome: a study of two families. ⁶¹	Castro ABBS...Avila MP	30328943	2018
125	Technique, postoperative complications, and visual outcomes of phacoemulsification cataract surgery in 21 penguins (27 eyes): 2011-2015. ⁶¹	Church ML...Davis M	29411487	2018
126	Recurrent epibulbar dermoid cyst treated with amniotic membrane implant a case report. ⁶¹	Villalon ML...Almanza H	30428870	2018
127	Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo. ⁶¹	Wakakura M...Iwasa M	30258472	2018
128	Clinical Features of Benign Essential Blepharospasm in Korean Patients. ⁶¹	Lee JM...Jang JW	30311455	2018
129	Developments in the treatment of benign essential blepharospasm. ⁶¹	Yen MT	29916840	2018
130	Neuro-Ophthalmology at a Tertiary Eye Care Centre in India. ⁶¹	Dhiman R...Saxena R	29135814	2018
131	Botulinum neurotoxin for the treatment of movement disorders. ⁶¹	Kopanidis P...Das C	30244558	2018
132	Botulinum toxin injection and tear production. ⁶¹	Alsuhaibani AH...Eid SA	29994851	2018
133	Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology. ⁶¹	Bilyk JR...Mawn LA	29653859	2018
134	Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm. ⁶¹	Weiss D...Wachter T	29990961	2018
135	Evaluation of Scheimpflug imaging parameters in blepharospasm and normal eyes. ⁶¹	Zhang H...Ye J	30185154	2018
136	[The patterns analysis of clinical application of acupuncture for ophthalmopathy]. ⁶¹	Zhi F...Ma X	30141305	2018
137	The impact of deep brain stimulation on health related quality of life and disease-specific disability in Meige Syndrome (MS). ⁶¹	Aires A...Vaz R	29807200	2018
138	Blepharospasm with elevated anti-acetylcholine receptor antibody titer. ⁶¹	Tang M...Meng F	30231125	2018
139	The Ex vivo Eye Irritation Test (EVEIT) model as a mean of improving venom ophthalmia understanding. ⁶¹	Delafontaine M...Tambourgi DV	29890230	2018
140	Stroke-induced resolution of primary blepharospasm: evidence for the lenticular nucleus as a control candidate. ⁶¹	Bladen JC...Ezra DG	30049673	2018
141	Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm. ⁶¹	Namiguchi K...Shiraishi A	29641935	2018
142	An unusual case of feline acute corneal hydrops: atypical disease presentation and possible in vivo detection of Descemet's membrane detachment in the cat's unaffected eye. ⁶¹	Schlesener BN...Vallone LV	29111586	2018
143	An Aesthetic Orbicularis Oculi Myectomy Technique for Blepharospasm: Use of Topical 5-Fluorouracil and Fibrin Sealant. ⁶¹	Stewart KJ...Douglas RS	28863116	2018
144	Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity - Insights from recent studies. ⁶¹	Wissel J	29407165	2018
145	Evidence on botulinum toxin in selected disorders. ⁶¹	Zakin E...Simpson D	29408357	2018
146	[Botulinum Toxin - New Developments in Ophthalmology]. ⁶¹	Wabbels B	28114700	2018
147	Recent developments in clinical trials of botulinum neurotoxins. ⁶¹	Cocco A...Albanese A	28818530	2018
148	Spinocerebellar Ataxia Type 31 with Blepharospasm. ⁶¹	Itaya S...Shintani S	29434122	2018
149	An update on new and unique uses of botulinum toxin in movement disorders. ⁶¹	Jankovic J	28888928	2018
150	Keratitis due to microfilariae in dogs: a newly recognized disease. ⁶¹	Morales A...Safatle AMV	28508467	2018
151	Diagnosis of primary hemifacial spasm. ⁶¹	Lefaucheur JP...Le Guerinel C	29673578	2018
152	Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm. ⁶¹	Ho RW...Kuo MT	29849166	2018
153	Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm. ⁶¹	Wagle Shukla A...Hallett M	29530449	2018
154	Whole-exome sequencing for variant discovery in blepharospasm. ⁶¹	Tian J...LeDoux MS	29770609	2018
155	Clinical management of Candida albicans keratomycosis in a bottlenose dolphin (Tursiops truncatus). ⁶¹	Simeone CA...Jensen ED	28074638	2018
156	Effect of Botulinum Toxin A on Muscle Healing and its Implications in Aesthetic and Reconstructive Surgery. ⁶¹	Silberstein E...Krieger Y	29145580	2018
157	Injecting botulinum toxin into the treatment of blepharospasm. ⁶¹	Popescu MN...Musat O	30206561	2018
158	[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia]. ⁶¹	Garcia-Ruiz PJ...Pena-Segura JL	29480513	2018
159	Botulinum toxin in movement disorders. ⁶¹	Tater P...Pandey S	29503330	2018
160	Modified brow suspension technique for the treatment of pseudoptosis due to redundant frontal skin in the dog: a retrospective study of 25 cases. ⁶¹	Cairo M...Pena MT	28444838	2018
161	Protective Effect of Blepharospasm on the Anterior Segment of the Eye. ⁶¹	Biuk D...Matic S	30256021	2018
162	Botulinum Toxin Treatment of Movement Disorders. ⁶¹	Safarpour Y...Jabbari B	29478149	2018
163	Botulinum toxin therapy in patients with oral anticoagulation: is it safe? ⁶¹	Schrader C...Dressler D	29116410	2018
164	Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm. ⁶¹	Lee S...Lew H	29376224	2018
165	Blepharospasm and Hemifacial Spasm. ⁶¹	Yen MT	29239872	2018
166	Botulinum Toxins for Treating Essential Blepharospasm and Hemifacial Spasm. ⁶¹	Ozzello DJ...Giacometti JN	29239877	2018
167	Surgical Myectomy for Essential Blepharospasm and Hemifacial Spasm. ⁶¹	Yen MT	29239878	2018
168	Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease. ⁶¹	Baiardi S...Parchi P	30010123	2018
169	Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis? ⁶¹	Catai LMP...Teive HAG	30008965	2018
170	[Tarsal Kink: Pathognomonic Presentation and Therapy of a Rare Congenital Upper Eyelid Malformation]. ⁶¹	Schaudig U...Keseru M	29373869	2018
171	Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan. ⁶¹	Sun Y...Bee YS	30586395	2018
172	Brueghel Syndrome or Meige Syndrome? Two Sides of a Same Disease. ⁶¹	Bereau M...Tatu L	29145188	2018
173	Long-term outcome of pallidal stimulation for Meige syndrome. ⁶¹	Horisawa S...Taira T	29350600	2018
174	Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure. ⁶¹	Berman BD...Nagae LM	30013924	2018
175	Sexual dysfunction in cervical dystonia and blepharospasm. ⁶¹	Marek M...Paus S	30464469	2018
176	[Non-motor disorders in patients with muscular dystonia]. ⁶¹	Salouchina NI...Tolmacheva VA	30335080	2018
177	The Facial Nerve and Selective Neurectomy for Treatment of Benign Essential Blepharospasm. ⁶¹	Weller C...Leyngold I	29239881	2018
178	Benign Essential Blepharospasm: What We Know and What We Don't. ⁶¹	Hwang CJ...Eftekhari K	29239874	2018
179	The Benign Essential Blepharospasm Research Foundation. ⁶¹	Moore GH...Anderson RL	29239875	2018
180	Oral Pharmacotherapy for Benign Essential Blepharospasm. ⁶¹	Hirabayashi KE...Vagefi MR	29239876	2018
181	Dystonia. ⁶¹	Barbosa P...Warner TT	30482316	2018
182	Voxel-Mirrored Homotopic Connectivity of Resting-State Functional Magnetic Resonance Imaging in Blepharospasm. ⁶¹	Wei J...Guo W	30254593	2018
183	Botulinum toxin in Meige's syndrome: A video-based case series. ⁶¹	Pandey S...Sharma S	29322963	2018
184	Altered functional connectivity in blepharospasm/orofacial dystonia. ⁶¹	Jochim A...Haslinger B	29568690	2018
185	The History of Blepharospasm in Medicine. ⁶¹	Hamill EB...Yen MT	29239873	2018
186	Secondary Blepharospasm Associated With Ocular Surface Disease. ⁶¹	Lee S...Yen MT	29239879	2018
187	Changes in interleukin-6 tear concentration and clinical outcome in moderate-to-severe bacterial corneal ulcers after corneal collagen cross-linking. ⁶¹	Erlangga MD...Pawiroranu S	30140651	2018
188	123I-FP-CIT SPECT imaging in blepharospasm. ⁶¹	De Verdal M...Castelnovo G	28629634	2017
189	Muscle Selection for Focal Limb Dystonia. ⁶¹	Karp BI...Alter K	29286305	2017
190	Long-term clinical outcome of bilateral pallidal stimulation for intractable craniocervical dystonia (Meige syndrome). Report of 6 patients. ⁶¹	Sobstyl M...Zabek M	29246604	2017
191	[Modern non-cosmetic treatment with botulinum toxins]. ⁶¹	Straube A	29030680	2017
192	Plasmatic coagulation and fibrinolysis in healthy and Otostrongylus-affected Northern elephant seals (Mirounga angustirostris). ⁶¹	Kaye S...Fletcher DJ	28902964	2017
193	Temporal horizontal H-figure sliding skin flap for central eyelid reconstructive surgery in dogs: a retrospective study. ⁶¹	Giordano C...Barsotti G	28944479	2017
194	A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques. ⁶¹	Lolekha P...Kulkantrakorn K	28884242	2017
195	Resting state fMRI observations of baseline brain functional activities and connectivities in primary blepharospasm. ⁶¹	Ni MF...Liang ZH	28893588	2017
196	Ocular Effects of Sulfur Mustard and Therapeutic Approaches. ⁶¹	Panahi Y...Sahebkar A	28106291	2017
197	Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation. ⁶¹	Radke PM...Harrison AR	29339959	2017
198	Treatment of Blepharospasm/Hemifacial Spasm. ⁶¹	Green KE...Eggenberger E	28965229	2017
199	Corneal anesthetic effect and ocular tolerance of 3.5% lidocaine gel in comparison with 0.5% aqueous proparacaine and 0.5% viscous tetracaine in normal canines. ⁶¹	Venturi F...Brinkis J	27981712	2017
200	Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study. ⁶¹	Tofflemire K...Whitley RD	27791324	2017
201	Sensitivity of Diagnostic Tests for Dry Eye in Patients with Blepharospasm. ⁶¹	Biuk D...Benasic T	29479902	2017
202	INCREASED BLINKING MAY BE A PRECURSOR OF BLEPHAROSPASM: A LONGITUDINAL STUDY. ⁶¹	Conte A...Berardelli A	29082270	2017
203	Photophobia in primary headaches, in essential blepharospasm and in major depression. ⁶¹	Anagnostou E...Kararizou E	27580344	2017
204	Bilateral pallidotomy for Meige syndrome. ⁶¹	Minkin K...Romansky K	28424916	2017
205	Canine ocular onchocerciasis: a retrospective review of the diagnosis, treatment, and outcome of 16 cases in New Mexico (2011-2015). ⁶¹	McLean NJ...Adema CM	27624855	2017
206	Role of the "other Babinski sign" in hyperkinetic facial disorders. ⁶¹	Varanda S...Carneiro G	28566174	2017
207	Unilateral pallidotomy for blepharospasm refractory to botulinum toxin injections. ⁶¹	Horisawa S...Taira T	28643956	2017
208	Clinical heterogeneity in patients with idiopathic blepharospasm: A cluster analysis. ⁶¹	Defazio G...Berardelli A	28476326	2017
209	Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study. ⁶¹	Sane S...Naik M	29022290	2017
210	A 72-year-old with eyelid opening apraxia in Steele-Richardson-Olszewski syndrome. ⁶¹	Qureshi IA...Maud A	28588873	2017
211	Blepharospasm as a masquerade of glaucomatous visual field defects. ⁶¹	Dikopf MS...Vajaranant TS	28576231	2017
212	Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery. ⁶¹	Kashkouli MB...Abtahi MB	26020714	2017
213	Sensory tricks in primary blepharospasm and idiopathic cervical dystonia. ⁶¹	Pandey S...Sarma N	28488615	2017
214	The Italian Dystonia Registry: rationale, design and preliminary findings. ⁶¹	Defazio G...Berardelli A	28215037	2017
215	Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela. ⁶¹	Yepez JB...Johns Hopkins Zika Center	28418539	2017
216	Botulinum Toxin Therapy for Parkinson's Disease. ⁶¹	Wagle Shukla A...Malaty IA	28511260	2017
217	Blepharospasm 40 years later. ⁶¹	Defazio G...Berardelli A	28186662	2017
218	Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa. ⁶¹	Tsai JC	29018766	2017
219	Botulinum toxin in the management of head and neck disorders. ⁶¹	Nagi R...Naidu GS	28159584	2017
220	Cluster Headache Associated with Secondary Unilateral Blepharospasm: A Case Report and Review of the Literature. ⁶¹	Bagheri A...Yazdani S	28540017	2017
221	Pontine Tegmental Cap Dysplasia in an Extremely Preterm Infant and Review of the Literature. ⁶¹	Picker-Minh S...Kaindl AM	28193110	2017
222	Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. ⁶¹	Yang J...Shang HF	28239516	2017
223	Dystonia treatment: Patterns of medication use in an international cohort. ⁶¹	Pirio Richardson S...Dystonia Coalition Investigators	28077492	2017
224	Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results. ⁶¹	Dressler D...Laskawi R	27816991	2017
225	Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease. ⁶¹	Hamedani AG...Gold DR	28769865	2017
226	Genetic screening of THAP1 in primary dystonia patients of India. ⁶¹	Giri S...Ray J	27913194	2017
227	Does the Somatosensory Temporal Discrimination Threshold Change over Time in Focal Dystonia? ⁶¹	Conte A...Berardelli A	29062576	2017
228	Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment. ⁶¹	Pandey S...Sharma S	28017205	2017
229	Treatment of blepharospasm with apraclonidine. ⁶¹	Vijayakumar D...Jankovic J	28017248	2017
230	Multiple Neural Networks Malfunction in Primary Blepharospasm: An Independent Components Analysis. ⁶¹	Huang XF...Luo YY	28539879	2017
231	Temporal Discrimination: Mechanisms and Relevance to Adult-Onset Dystonia. ⁶¹	Conte A...Hutchinson M	29234300	2017
232	Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia. ⁶¹	Leplow B...Pohl J	29066869	2017
233	Acute Dystonic Reaction Following General Anesthetic Agent Use. ⁶¹	Jitprapaikulsan J...Srivanitchapoom P	29204316	2017
234	How Many Dystonias? Clinical Evidence. ⁶¹	Albanese A	28217105	2017
235	Photophobia in neurologic disorders. ⁶¹	Wu Y...Hallett M	28932391	2017
236	Exploratory structural assessment in craniocervical dystonia: Global and differential analyses. ⁶¹	Vilany L...D'Abreu A	28829782	2017
237	Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in Ireland. ⁶¹	Williams L...Hutchinson M	27647704	2017
238	A Dynamic Circuit Hypothesis for the Pathogenesis of Blepharospasm. ⁶¹	Peterson DA...Sejnowski TJ	28326032	2017
239	Blepharospasm: an uncommon adverse effect caused by long-term administration of olanzapine. ⁶¹	Arora T...Nagar P	27658142	2017
240	Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm. ⁶¹	Clark J...Nunery WR	29403334	2017
241	Transcranial direct current stimulation for patients with benign essential blepharospasm: a case report. ⁶¹	Trebossen V...Januel D	27672032	2017
242	Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India. ⁶¹	Raj A...Bamotra RK	27078720	2017
243	The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review. ⁶¹	Awan KH	28223858	2017
244	Episcleral cyclosporine A implants for the management of unilateral keratoconjunctivitis sicca in an 8-year-old mare. ⁶¹	Mackenzie CJ...Malalana F	26945681	2017
245	Management of Essential Blepharospasm. ⁶¹	Clayman E...Harrington MA	28680527	2017
246	Depression in blepharospasm: a question of facial feedback? ⁶¹	Bedarf JR...Paus S	28761348	2017
247	Intractable Blepharospasm Treated with Bilateral Pallidal Deep Brain Stimulation. ⁶¹	Luthra NS...Ostrem JL	28975046	2017
248	Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy. ⁶¹	Hanganu A...Groppa S	28192485	2017
249	Improvement of Orbitofrontal Cortex Function Associated with Blephrospasm Symptom Remission. ⁶¹	Shen CY...Liu PZ	28391280	2017
250	Use of Botulinum Neurotoxin in Ophthalmology. ⁶¹	Basar E...Arici C	28050326	2016
251	The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial. ⁶¹	Wanitphakdeedecha R...Manuskiatti W	27647769	2016
252	A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics. ⁶¹	Blackburn PR...Atwal PS	27919237	2016
253	Chewing-induced blepharospasm in Parkinson's disease. ⁶¹	Spitz M...Pereira JS	27871438	2016
254	Psychogenic Blepharospasm: A Diagnostic Dilemma. ⁶¹	DAS S...Saji CV	28638211	2016
255	Alleviating Maneuvers for Benign Essential Blepharospasm and Hemifacial Spasm. ⁶¹	Lee AG...Miller NR	27607413	2016
256	Use of Alleviating Maneuvers for Periocular Facial Dystonias. ⁶¹	Kilduff CL...Ezra D	27606483	2016
257	Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB. ⁶¹	Isshiki Y...Mimura O	27503401	2016
258	Objective, computerized video-based rating of blepharospasm severity. ⁶¹	Peterson DA...Sejnowski TJ	27770067	2016
259	Effect of topical administration of tramadol on corneal wound healing in rats. ⁶¹	Cuvas Apan O...Sengul D	26820482	2016
260	Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. ⁶¹	Lamb R...Morris HR	27526039	2016
261	Meta-analytical and electrophysiological evidence for executive dysfunction in primary dystonia. ⁶¹	Lange F...Kopp B	27376933	2016
262	IncobotulinumtoxinA: A Review in Upper Limb Spasticity. ⁶¹	Lamb YN...Scott LJ	27530616	2016
263	Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case Report. ⁶¹	Yoshimura R...Atake K	27627971	2016
264	Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment. ⁶¹	Jog M...Trentin G	27430524	2016
265	Role of GABAergic System in Blepharospasm. ⁶¹	Suzuki Y...Kiyosawa M	27533531	2016
266	Role of GABAergic System in Blepharospasm: Response. ⁶¹	Evinger C...Digre K	27533532	2016
267	A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm. ⁶¹	Fezza J...Verma A	27423565	2016
268	Aesthetic and Non-aesthetic Indications for Orbicularis Oculi Myectomy. ⁶¹	Viterbo F...Brock RS	27178568	2016
269	The wrong end of the telescope: neuromuscular mimics of movement disorders (and vice versa). ⁶¹	Bloem BR...van de Warrenburg BP	26965497	2016
270	Cognitive Flexibility in Primary Dystonia. ⁶¹	Lange F...Kopp B	27333537	2016
271	Diagnosis, pathophysiology, and treatment of photophobia. ⁶¹	Katz BJ...Digre KB	26875996	2016
272	Erratum to: 'Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial'. ⁶¹	Wickwar S...Ezra DG	27439615	2016
273	Meige's syndrome. ⁶¹	Gautam P...Rathi A	28659707	2016
274	Orbicularis Oculi Myectomy as a Treatment for Blepharospasm in a Case of Schwartz Jampel Syndrome. ⁶¹	Eshraghi B...Pour EK	27621795	2016
275	Successful Treatment of Blepharospasm by Pallidal Neurostimulation. ⁶¹	Santos AF...Volkmann J	30713932	2016
276	Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Payment policy perspectives. ⁶¹	Govindarajan R...Chen JJ	29443136	2016
277	In vivo confocal microscopy of meibomian glands in primary blepharospasm: A prospective case-control study in a Chinese population. ⁶¹	Lin T...Gong L	27281086	2016
278	INTRAOCULAR SILICONE BALL IMPLANTATION AFTER EVISCERATION IN A SLOW LORIS (NYCTICEBUS COUCANG). ⁶¹	Kim J...Kim MS	27468037	2016
279	Strategies for the Management of Congenital Iris Cysts. ⁶¹	Chaudhry S...Smith J	27376231	2016
280	Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia Circuit. ⁶¹	Park J	27240808	2016
281	Language modulation of benign essential blepharospasm. ⁶¹	Waxman J...Ezra DG	26990543	2016
282	Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. ⁶¹	Simpson DM...Yablon SA	27164716	2016
283	Botulinum toxin therapy: reduction of injection site pain by pH normalisation. ⁶¹	Dressler D...Bigalke H	27002815	2016
284	Movement disorders induced by deep brain stimulation. ⁶¹	Baizabal-Carvallo JF...Jankovic J	26806438	2016
285	Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia: A Cross-sectional Study. ⁶¹	Zhang Y...Liu CF	27064039	2016
286	Sleep in patients with primary dystonia: A systematic review on the state of research and perspectives. ⁶¹	Hertenstein E...Sandhu HK	26164369	2016
287	Sun exposure is an environmental factor for the development of blepharospasm. ⁶¹	Molloy A...Hutchinson M	25904812	2016
288	Blepharospasm in a multiplex African-American pedigree. ⁶¹	Xiao J...LeDoux MS	26944167	2016
289	Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia. ⁶¹	Tilden D...Guarnieri C	27021747	2016
290	Pallidal stimulation for medically intractable blepharospasm. ⁶¹	Yamada K...Kuratsu J	27033410	2016
291	Behavioural interventions for people living with adult-onset primary dystonia: a systematic review. ⁶¹	Bernstein CJ...Sandhu H	27000094	2016
292	Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. ⁶¹	Scaglione F	26959061	2016
293	Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial. ⁶¹	Wickwar S...Ezra DG	26961367	2016
294	DEVELOPMENT OF RETROBULBAR AND AURICULOPALPEBRAL NERVE BLOCKS IN CALIFORNIA SEA LIONS (ZALOPHUS CALIFORNIANUS). ⁶¹	Gutierrez J...Johnson S	27010283	2016
295	Ophthalmic abnormalities secondary to periocular or ocular snakebite (pit vipers) in dogs--11 cases (2012-2014). ⁶¹	Martins BC...Schaer M	25912317	2016
296	Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. ⁶¹	Karp BI...Alter K	26866500	2016
297	[Sandifer's syndrome in a 5-month-old child with suspicion of infantile spasms]. ⁶¹	Wirth M...Leheup B	26697813	2016
298	Botulinum Toxin for the Treatment of Tremor and Tics. ⁶¹	Lotia M...Jankovic J	26866497	2016
299	Blepharospasm in children and adolescents. ⁶¹	Kinard K...Warner JE	26510653	2016
300	Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm. ⁶¹	Yang H...Lu L	26885381	2016
301	A Survey of Current Blepharospasm Treatment Patterns Among Oculoplastic Surgeons. ⁶¹	Broadbent TJ...Mawn LA	25811162	2016
302	High prevalence of primary focal dystonia in the Faroe Islands. ⁶¹	Joensen P	26041438	2016
303	Non-motor symptoms in patients with adult-onset focal dystonia: Sensory and psychiatric disturbances. ⁶¹	Conte A...Fabbrini G	26360238	2016
304	Psychogenic Ophthalmologic Movement Disorders. ⁶¹	Baizabal-Carvallo JF...Jankovic J	26792096	2016
305	Late-onset primary dystonia in Zhejiang province of China: a service-based epidemiological study. ⁶¹	Wang L...Hu X	26306696	2016
306	Blepharospasm: Update on Epidemiology, Clinical Aspects, and Pathophysiology. ⁶¹	Valls-Sole J...Defazio G	27064462	2016
307	Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe? ⁶¹	Fraint A...Comella C	26917963	2016
308	Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy. ⁶¹	Alexandru H...Groppa S	27992533	2016
309	Functional facial and tongue movement disorders. ⁶¹	Fasano A...Tinazzi M	27719855	2016
310	Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study. ⁶¹	Perozzo P...Ricci R	27761118	2016
311	Bleb incarceration following Ahmed valve surgery. ⁶¹	Gross FJ...DiSandro G	27799829	2016
312	Edrophonium Challenge Test for Blepharospasm. ⁶¹	Matsumoto S...Kaji R	27375406	2016
313	Dorsally located corneal dermoid in a cat. ⁶¹	LoPinto AJ...Beamer G	28491417	2016
314	Prefrontal Hemodynamic Functions during a Verbal Fluency Task in Blepharospasm Using Multi-Channel NIRS. ⁶¹	Shen CY...Liu PZ	26942579	2016
315	Screening for Cognitive Impairments in Primary Blepharospasm. ⁶¹	Yang J...Shang HF	27526026	2016
316	Kikuchi-Fujimoto disease presenting as brainstem encephalitis with secondary blepharospasm. ⁶¹	Jasti DB...Vengamma B	26933369	2016
317	Clinical differences between botulinum neurotoxin type A and B. ⁶¹	Bentivoglio AR...Ricciardi L	26260691	2015
318	Malassezia pachydermatis keratomycosis in a dog. ⁶¹	Ledbetter EC...Starr JK	26909245	2015
319	Ultraviolet Keratitis: From the Pathophysiological Basis to Prevention and Clinical Management. ⁶¹	Willmann G	26680683	2015
320	Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials. ⁶¹	Del Sorbo F...Albanese A	26365917	2015
321	Is it time for flexibility in botulinum inter-injection intervals? ⁶¹	Ojo OO...Fernandez HH	26440738	2015
322	Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department. ⁶¹	Tomic A...Kostic VS	26898029	2015
323	Patients with ocular symptoms referred for electrodiagnosis: how many of them suffer from myasthenia gravis? ⁶¹	Zambelis T...Karandreas N	25822064	2015
324	Benign Essential Blepharospasm is a Disorder of Neuroplasticity: Lessons From Animal Models. ⁶¹	Evinger C	26576017	2015
325	Benign Essential Blepharospasm--There Is More to It Than Just Blinking. ⁶¹	Digre KB	26576018	2015
326	How Do I Examine Blepharospasm? ⁶¹	Colosimo C...Berardelli A	30838249	2015
327	Clinicopathological effects of pepper (oleoresin capsicum) spray. ⁶¹	Yeung MF...Tang WY	26554271	2015
328	Changes in corneal aesthesiometry and the sub-basal nerve plexus in benign essential blepharospasm. ⁶¹	Fayers T...Ezra DG	25904123	2015
329	The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients. ⁶¹	Patel AB...Crujido L	26024910	2015
330	Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses. ⁶¹	Pinto NI...Gilger BC	25399915	2015
331	Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design. ⁶¹	Punga AR...Alimohammadi M	25766591	2015
332	Effects of morphine on the expression of cytokines and inflammatory mediators in a rabbit model of endotoxin-induced experimental uveitis. ⁶¹	Ortencio KP...Laus JL	26677041	2015
333	Autoimmune post-herpes simplex encephalitis of adults and teenagers. ⁶¹	Armangue T...Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis	26491084	2015
334	Functional Vision Disorder. ⁶¹	Egan RA...LaFrance WC	26444401	2015
335	Combined Excimer Laser Photoablation and Amniotic Membrane Overlay for Relief of Symptomatic Discomfort in Gelatinous Drop-like Corneal Dystrophy. ⁶¹	Alex AF...Uhlig CE	26203750	2015
336	A case of thrombosis of subcutaneous anterior chest veins (Mondor's disease) as an unusual complication of botulinum type A injection. ⁶¹	Pisani LR...Calabro RS	26126167	2015
337	Eyelid myokymia in patients with migraine taking topiramate. ⁶¹	Medrano-Martinez V...Piqueras-Rodriguez L	25828425	2015
338	Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm. ⁶¹	Gunes A...Tok O	26075455	2015
339	Use of bandage contact lenses for treatment of spontaneous chronic corneal epithelial defects in dogs. ⁶¹	Grinninger P...Boeve MH	25882569	2015
340	Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine. ⁶¹	Kilic A...Ozdemir A	28360708	2015
341	Riot control agents: the tear gases CN, CS and OC-a medical review. ⁶¹	Schep LJ...McBride DI	24379300	2015
342	Oral methylphenidate for the treatment of refractory facial dystonias. ⁶¹	Eftekhari K...Eckstein LA	25951177	2015
343	The role of neurotoxins in the periorbital and midfacial areas. ⁶¹	Erickson BP...Grunebaum LD	25921574	2015
344	Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children. ⁶¹	Arbizu RA...Rodriguez L	25992183	2015
345	The spread of primary late-onset focal dystonia in a long-term follow up study. ⁶¹	Svetel M...Kostic VS	25764999	2015
346	Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm. ⁶¹	Kent TL...Holds JB	25192329	2015
347	Efficacy of high dose methylprednisolone in a patient with cervical dystonia and blepharospasm and Sjögren's syndrome. ⁶¹	Mantero V...Salmaggi A	25060651	2015
348	Histiocytic Sarcoma and Bilateral Facial Vein Thrombosis in a Siberian Hamster (Phodopus sungorus). ⁶¹	Coble DJ...Bolon B	25926398	2015
349	Development and validation of a clinical scale for rating the severity of blepharospasm. ⁶¹	Defazio G...Berardelli A	25847472	2015
350	Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm. ⁶¹	Sung Y...Lew H	25829828	2015
351	Botulinum toxin and blink rate in patients with blepharospasm and increased blinking. ⁶¹	Ferrazzano G...Berardelli A	24963123	2015
352	Diagnostic delay in adult-onset dystonia: data from an Italian movement disorder center. ⁶¹	Macerollo A...Defazio G	25577433	2015
353	Botulinum toxin in the management of blepharospasm: current evidence and recent developments. ⁶¹	Hellman A...Torres-Russotto D	25922620	2015
354	Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. ⁶¹	Kollewe K...Dressler D	25059456	2015
355	Ocular alkaline injury in four dogs - presentation, treatment, and follow-up - a case series. ⁶¹	Busse C...Pivetta M	24836701	2015
356	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study. ⁶¹	Bal C...Tambyah PA	25662592	2015
357	Clinical categorization of psychogenic blepharospasm. ⁶¹	Gazulla J...Modrego P	25558013	2015
358	Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage. ⁶¹	Osaki T...Hofling-Lima AL	25717119	2015
359	Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. ⁶¹	Grosset DG...Grosset KA	25325305	2015
360	[Unilateral loss of eyebrows and repeated botulinum toxin injections: questionable correlation in essential blepharospasm]. ⁶¹	Wabbels B...Stanzel BV	25566735	2015
361	Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure. ⁶¹	Hoppel M...Valenta C	25497319	2015
362	Recognizing uncommon presentations of psychogenic (functional) movement disorders. ⁶¹	Baizabal-Carvallo JF...Fekete R	25667816	2015
363	Clinical Analysis of Patients with Primary Blepharospasm: A Report of 100 Cases in China. ⁶¹	Huang XF...Zhou LN	25997849	2015
364	Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. ⁶¹	Dashtipour K...Tagliati M	26566457	2015
365	Primary congenital glaucoma. ⁶¹	Ko F...Khaw PT	26518078	2015
366	Functional Aspects of Gait in Essential Tremor: A Comparison with Age-Matched Parkinson's Disease Cases, Dystonia Cases, and Controls. ⁶¹	Louis ED...Rao AK	26056611	2015
367	Aripiprazole Can Improve Apraxia of Eyelid Opening in Parkinson's Disease. ⁶¹	Tokisato K...Yamanaga H	26631893	2015
368	White Matter Microstructure in Idiopathic Craniocervical Dystonia. ⁶¹	Pinheiro GL...D'Abreu A	26056610	2015
369	An update on the use of botulinum toxin therapy in Parkinson's disease. ⁶¹	Mills R...Pagan F	25407133	2015
370	Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. ⁶¹	Jost WH...Comella CL	25897202	2015
371	Bilateral ptosis: Lesion in the oculomotor nuclei or supranuclear lesion? ⁶¹	Dimitriou J...Diserens K	26409335	2015
372	Postanaesthetic tear production and ocular irritation in cats. ⁶¹	Peche N...Pieper K	25599242	2015
373	Use of botulinum toxin injections to treat peripheral stimulator induced facial muscle twitching: a case report. ⁶¹	Trentman TL...Rosenfeld DM	26558174	2015
374	[Meige's syndrome or segmental craniocervical dystonia: terminology, history and contemporary view]. ⁶¹	Zalyalova ZA	26978507	2015
375	Globe penetration in a cat following maxillary nerve block for dental surgery. ⁶¹	Perry R...Scurrell E	25527494	2015
376	Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management. ⁶¹	Dodi PL	30101119	2015
377	A gait paradigm reveals different patterns of abnormal cerebellar motor learning in primary focal dystonias. ⁶¹	Hoffland BS...van de Warrenburg BP	25182695	2014
378	Mycotic Keratitis in a Khaki Campbell Duck ( Anas platyrhynchos domesticus). ⁶¹	Sadar MJ...Hollingsworth SR	25843471	2014
379	Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. ⁶¹	Streitova H...Bares M	24604684	2014
380	BOTOX: Broadening the Horizon of Dentistry. ⁶¹	Nayyar P...Singh A	25654058	2014
381	Blink reflex studies in postparalytic facial syndrome and blepharospasm: trigeminal and extratrigeminal somatosensory stimulation. ⁶¹	Benbir G...Kiziltan ME	25462139	2014
382	Blepharospasm in familial AD secondary to an APP mutation (V715M). ⁶¹	Nan SJ...Chen QH	24677022	2014
383	Visual signs and symptoms of multiple system atrophy. ⁶¹	Armstrong RA	25256122	2014
384	IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. ⁶¹	Evidente VG...Hanschmann A	25186131	2014
385	Ophthalmomyiasis interna anterior in a dog: keratotomy and extraction of a Cuterebra sp. larva. ⁶¹	Edelmann ML...Ledbetter EC	25186977	2014
386	Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. ⁶¹	Ramirez-Castaneda J...Jankovic J	25130293	2014
387	Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection. ⁶¹	Kocabeyoglu S...Sanac AS	24803156	2014
388	Surgical correction of congenital entropion in related Boer goat kids using a combination Hotz-Celsus and lateral eyelid wedge resection procedure. ⁶¹	Donnelly KS...Middleton JR	25338664	2014
389	Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results. ⁶¹	Karapantzou C...Laskawi R	25338619	2014
390	Scientific skepticism and new discoveries: an analysis of a report of zinc/phytase supplementation and the efficacy of botulinum toxins in treating cosmetic facial rhytides, hemifacial spasm and benign essential blepharospasm. ⁶¹	Cohen JL	25105993	2014
391	Induction of corneal collagen cross-linking in experimental corneal alkali burns in rabbits. ⁶¹	Colombo-Barboza M...Sato EH	25494378	2014
392	Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions. ⁶¹	Huang L...Perry JD	24777259	2014
393	Transient blepharospasm, apraxia of eyelid opening, and hemidyskinesia following a right parietotemporal infarct. ⁶¹	Hsieh CY...Hwang WJ	24954061	2014
394	A direct comparison of onabotulinumtoxina (Botox) and IncobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm: a split-face technique. ⁶¹	Saad J...Gourdeau A	24739994	2014
395	Bilateral and Simultaneous Intraocular Lens Subluxation in Essential Blepharospasm. ⁶¹	Moreno-Montanes J...Riverol M	30363886	2014
396	Botulinum toxin therapy in congenital blepharospasm. ⁶¹	Wabbels B	25606035	2014
397	What's special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study. ⁶¹	Ramdhani RA...Simonyan K	24925463	2014
398	Facial dystonias and rosacea: is there an association? ⁶¹	Khan TT...Hesse RJ	24831933	2014
399	Adverse events associated with botulinum toxin injection: a multidepartment, retrospective study of 5310 treatments administered to 1819 patients. ⁶¹	Kim BW...Lee MW	23537074	2014
400	Distichiasis in a ferret (Mustela putorius furo). ⁶¹	Verboven CA...Boeve MH	24118780	2014
401	Diffusion tensor imaging in blepharospasm and blepharospasm-oromandibular dystonia. ⁶¹	Yang J...Shang HF	24792726	2014
402	BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis. ⁶¹	Gomez-Garre P...Mir P	24925604	2014
403	Treatment of six cases of equine corneal stromal abscessation with intracorneal injection of 5% voriconazole solution. ⁶¹	Smith KM...Gilmour MA	24387183	2014
404	Pain control in horses: what do we really know? ⁶¹	Sanchez LC...Robertson SA	24645799	2014
405	Blepharospasm with non-satisfactory response to treatment: our experience with IncobotulinumtoxinA. ⁶¹	Ricciardi L...Bentivoglio AR	24685658	2014
406	[Cost analysis of the use of botulinum toxin type A in Spain]. ⁶¹	de Andres-Nogales F...Casado MA	24951903	2014
407	The clinical spectrum of laryngeal dystonia includes dystonic cough: observations of a large series. ⁶¹	Payne S...Darveniza P	24753288	2014
408	A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. ⁶¹	Vemula SR...LeDoux MS	24936516	2014
409	Keratoconjunctivitis caused by an unusual retained conjunctival foreign body: a frequently unrecognized entity. ⁶¹	Kalavathy CM...Thomas PA	24881616	2014
410	The setting of a botulinum toxin treatment service. ⁶¹	Cavallini M	24867836	2014
411	Intraerythrocytic iridovirus in central bearded dragons (Pogona vitticeps). ⁶¹	Grosset C...Weber ES	24855223	2014
412	Current uses of botulinum toxin A as an adjunct to hand therapy interventions of hand conditions. ⁶¹	Kalliainen LK...O'Brien VH	24524884	2014
413	Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. ⁶¹	Ababneh OH...Kulwin DR	23844601	2014
414	Motor vehicle accidents and injuries in patients with idiopathic blepharospasm. ⁶¹	Hwang WJ...Tsai CF	24507853	2014
415	A golden retriever with bilateral blepharospasm and ocular discharge. ⁶¹	Hagedorn TM...Komaromy AM	24651787	2014
416	Usefulness of FEES and responsiveness to tetrabenazine in a case of blepharospasm associated with dystonic-tremorous dsyphagia. ⁶¹	Suttrup I...Warnecke T	24495710	2014
417	The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. ⁶¹	Lu R...Li Q	24269849	2014
418	The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm. ⁶¹	Esposito M...Santoro L	23949734	2014
419	[Changes in dose and injection pattern in the botulinum toxin long-term therapy of facial dyskinesis]. ⁶¹	Laskawi R...Rohrbach S	24323508	2014
420	Successful medical treatment for globe penetration following tooth extraction in a dog. ⁶¹	Guerreiro CE...Lowe RC	23869648	2014
421	Glucose hypermetabolism in the thalamus of patients with drug-induced blepharospasm. ⁶¹	Suzuki Y...Ishii K	24462606	2014
422	Mosapride (5HT4 agonist) in the treatment of blepharospasm. ⁶¹	Piyasena IN...Jayasinghe JA	24682196	2014
423	[Blepharospasm as the presenting symptom of a brain stem glioma]. ⁶¹	Galvez-Ruiz AL	24570363	2014
424	Evaluating approaches to measuring ocular pain in bovine calves with corneal scarification and infectious bovine keratoconjunctivitis-associated corneal ulcerations. ⁶¹	Dewell RD...O'Connor AM	24504043	2014
425	Trigeminal high-frequency stimulation produces short- and long-term modification of reflex blink gain. ⁶¹	Ryan M...Evinger C	24285868	2014
426	Use of hydropulsion for the treatment of superficial corneal foreign bodies: 15 cases (1999-2013). ⁶¹	Labelle AL...Hamor RE	24479463	2014
427	Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". ⁶¹	Giacometti J...Yen MT	24398499	2014
428	Reply Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". ⁶¹	Chundury RV...Holds JB	24398500	2014
429	Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. ⁶¹	Fernandez HH...Pappert EJ	25120942	2014
430	Treatment of corneal cystine crystal accumulation in patients with cystinosis. ⁶¹	Shams F...Ramaesh K	25336909	2014
431	Pallidal deep brain stimulation in the treatment of Meige syndrome. ⁶¹	Sobstyl M...Zaczynski A	24981184	2014
432	A novel mutation in CLCN1 associated with feline myotonia congenita. ⁶¹	Gandolfi B...Lyons LA	25356766	2014
433	Optic nerve injury in a patient with chronic allergic conjunctivitis. ⁶¹	Hazin R...Bazzi A	25317346	2014
434	Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis. ⁶¹	Martinez-Ramirez D...Rodriguez RL	25562037	2014
435	Desensitization of the Mechanoreceptors in Müller's Muscle Reduces the Increased Reflex Contraction of the Orbicularis Oculi Slow-Twitch Fibers in Blepharospasm. ⁶¹	Matsuo K...Ban M	25328566	2014
436	Trigeminal Proprioception Evoked by Strong Stretching of the Mechanoreceptors in Müller's Muscle Induces Reflex Contraction of the Orbital Orbicularis Oculi Slow-Twitch Muscle Fibers. ⁶¹	Matsuo K...Yuzuriha S	25210572	2014
437	[Efficacy observation of acupuncture method of tonifying-qi and dredging-meridian for blepharospasm]. ⁶¹	Liu J...Zhang R	24673052	2014
438	Corneal sequestrum in a dog with chronic unilateral keratoconjunctivitis sicca. ⁶¹	Dubin AJ...Beamer GL	24299547	2013
439	Ulcerative fungal keratitis in a Brown Swiss cow. ⁶¹	Voelter-Ratson K...Spiess BM	23437914	2013
440	Association of the Val66Met polymorphism of the BDNF gene with primary cranial-cervical dystonia patients from South-west China. ⁶¹	Chen Y...Shang HF	23816543	2013
441	Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects. ⁶¹	Anwar MS...Zafar H	24550960	2013
442	Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study. ⁶¹	Yang J...Shang H	23900755	2013
443	Preliminary investigations into the analgesic effects of topical ocular 1% morphine solution in dogs and cats. ⁶¹	Thomson SM...Leece EA	23829875	2013
444	A resting state functional magnetic resonance imaging study of patients with benign essential blepharospasm. ⁶¹	Zhou B...Zhou D	23636105	2013
445	Myectomy for blepharospasm 2013. ⁶¹	Pariseau B...Anderson RL	23925062	2013
446	The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis. ⁶¹	Broide RS...Francis J	23707612	2013
447	Actinomyces bowdenii ulcerative keratitis in a dog. ⁶¹	Sherman A...Lutz E	23121462	2013
448	Feline thelaziosis caused by Thelazia callipaeda in Portugal. ⁶¹	Soares C...Otranto D	23611041	2013
449	Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm. ⁶¹	Truong DD...Xeomin US Blepharospasm Study Group	23435927	2013
450	The Babinski-2 sign in hemifacial spasm. ⁶¹	Pawlowski M...Evers S	23637014	2013
451	Secondary blepharospasm associated with structural lesions of the brain. ⁶¹	Khooshnoodi MA...Jinnah HA	23747003	2013
452	Blepharospasm as a new feature of cerebrotendinous xanthomatosis. ⁶¹	Lagarde J...Degos B	23623195	2013
453	Meige's Syndrome: Rare Neurological Disorder Presenting as Conversion Disorder. ⁶¹	Debadatta M...Mishra AK	24249940	2013
454	Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. ⁶¹	Czyz CN...Foster JA	23541393	2013
455	Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes. ⁶¹	Hubble J...Abbott CC	23783005	2013
456	Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence. ⁶¹	Ravenni R...Mazza A	23576131	2013
457	Bilateral parotid duct transposition for keratoconjunctivitis sicca in a Connemara stallion. ⁶¹	Montgomery K...Ducharme N	23067239	2013
458	Development and validation of a clinical guideline for diagnosing blepharospasm. ⁶¹	Defazio G...Berardelli A	23771487	2013
459	Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. ⁶¹	Hallett M...Jankovic J	23380701	2013
460	Dystonia rating scales: critique and recommendations. ⁶¹	Albanese A...Schrag A	23893443	2013
461	Is increased blinking a form of blepharospasm? ⁶¹	Conte A...Berardelli A	23751916	2013
462	Kinematic analysis of grasping in focal dystonia of the face and neck. ⁶¹	Nowak DA...Fink GR	23395859	2013
463	Tardive and spontaneous dyskinesia incidence in the general population. ⁶¹	Merrill RM...Matiaco PM	23714238	2013
464	Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm. ⁶¹	Chundury RV...Holds JB	23552607	2013
465	Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma. ⁶¹	Faiq M...Dada T	26997785	2013
466	Alleviation of abnormal synaptic neurotransmitter release by cell-permeable form of the truncated SNAP-25 upon transcutaneous delivery. ⁶¹	Park TY...Lee SK	23562512	2013
467	Patient-reported benefit from botulinum toxin treatment for essential blepharospasm: using 2 assessment scales. ⁶¹	Lee RM...Jones CA	23446304	2013
468	Skin contracture following upper eyelid orbiculectomy: is primary skin excision advisable? ⁶¹	Sagili S...Malhotra R	23565764	2013
469	The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. ⁶¹	Baizabal-Carvallo JF...Jankovic J	23400857	2013
470	Tremor in primary adult-onset dystonia: prevalence and associated clinical features. ⁶¹	Defazio G...Berardelli A	23142961	2013
471	Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin. ⁶¹	Gil Polo C...Duarte Garcia-Luis J	22652139	2013
472	Sensory tricks in focal dystonia and hemifacial spasm. ⁶¹	Loyola DP...Cardoso F	23216586	2013
473	Variability in the duration of the onset of idiopathic Parkinson's disease after essential blepharospasm. ⁶¹	Qayyum RA...Aysha A	23605608	2013
474	Long-term depression-like plasticity of the blink reflex for the treatment of blepharospasm. ⁶¹	Kranz G...Hallett M	23401198	2013
475	[Contribution of botulinum toxin to maxillo-facial surgery]. ⁶¹	Batifol D...Lorenzo S	23838244	2013
476	Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia. ⁶¹	Tinazzi M...Fiorio M	23404333	2013
477	Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. ⁶¹	Park DI...Lew H	23425111	2013
478	Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. ⁶¹	Lungu C...Hallett M	23146065	2013
479	THAP1 mutations in a Greek primary blepharospasm series. ⁶¹	Xiromerisiou G...Houlden H	23036512	2013
480	Successful integrative medicine case management of blepharospasm. ⁶¹	Stump JL...Boltz P	23046295	2013
481	Quality of life in patients with blepharospasm. ⁶¹	Biuk D...Stiglmayer N	23697247	2013
482	Schwartz Jampel syndrome in children. ⁶¹	Arya R...Gulati S	23219824	2013
483	An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. ⁶¹	Persaud R...Patel K	23476731	2013
484	Immunogenicity of botulinum toxins. ⁶¹	Naumann M...Gallagher CJ	23008029	2013
485	A case of Bell's palsy associated with blepharospasm. ⁶¹	Abou Dagher G...Tomlanovich M	22494605	2013
486	[Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use]. ⁶¹	Sheen-Ophir S...Almog Y	23513501	2013
487	The environmental epidemiology of primary dystonia. ⁶¹	Defazio G...Gigante AF	23724359	2013
488	Late onset atypical pantothenate-kinase-associated neurodegeneration. ⁶¹	Diaz N	23634310	2013
489	Animal models for investigating benign essential blepharospasm. ⁶¹	Evinger C	23814538	2013
490	Molecular Diagnostics and Genetic Counseling in Primary Congenital Glaucoma. ⁶¹	Faiq M...Dada T	26997777	2013
491	Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. ⁶¹	Fernandez HH...XCiDaBLE Study Group	23724362	2013
492	Effect of topical administration of 0.8% nalbuphine on the cornea in dogs after phacoemulsification. ⁶¹	Lee CH...Wang HC	23708961	2013
493	Clinical and ultrasonographic findings of some ocular conditions in sheep and goats. ⁶¹	El-Tookhy O...Tharwat M	26623306	2013
494	Dystonia. ⁶¹	Ryuji K	24112917	2013
495	Blink reflex in patients with postparalytic facial syndrome and blepharospasm: trigeminal and auditory stimulation. ⁶¹	Akalin MA...Benbir G	22854209	2013
496	Phenotypic expression of Bardet-Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene. ⁶¹	Cox KF...Iannaccone A	22940089	2012
497	Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm. ⁶¹	Li XH...Hong YC	23225838	2012
498	Botulinum toxins for facial lines: a concise review. ⁶¹	Lowe NJ...Lowe P	23205336	2012
499	A comparison of facial muscle squeezing versus non-facial muscle squeezing on the efficacy of botulinumtoxin-A injections for the treatment of facial dystonia. ⁶¹	O' Reilly P...Malhotra R	23061606	2012
500	[Value of simultaneous electromyographic recording of the levator palpebrae and the orbicularis oculi muscles as an early diagnostic marker for blepharospasm]. ⁶¹	Pardal-Fernandez JM...Mansilla-Lozano D	23172092	2012
501	Minimally invasive endoscopic endonasal management of skull base cholesterol granulomas. ⁶¹	Sade B...Lee JH	22120552	2012
502	Asymmetric blepharospasm with bilateral curtain sign. ⁶¹	de Souza A...Bhonsle SK	23157244	2012
503	Scedosporium apiospermum keratomycosis in a dog. ⁶¹	Newton EJ	22432768	2012
504	Crotoxin in humans: analysis of the effects on extraocular and facial muscles. ⁶¹	Ribeiro Gde B...Velarde DT	23715138	2012
505	Partial ligation of the transposed parotid duct at the level of the parotid gland for excessive salivary secretions. ⁶¹	Schilke HK...Sapienza JS	22385479	2012
506	Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review. ⁶¹	Colosimo C...Berardelli A	22359151	2012
507	Systemic mycosis in three dogs from nonendemic regions. ⁶¹	Pratt CL...Righter DJ	23033460	2012
508	[The application of Dysport® - the possibilities of the side effect on the eyelids position (a clinical - histological study)]. ⁶¹	Krasny J...Sach J	23461374	2012
509	Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia. ⁶¹	Defazio G...Berardelli A	22573394	2012
510	Blepharospasm cause and treatment: YouTube as a reflection of current popular thought. ⁶¹	Ehrlich MS...Woodward JA	23138220	2012
511	Psychogenic facial movement disorders: clinical features and associated conditions. ⁶¹	Fasano A...Espay AJ	23033125	2012
512	Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia. ⁶¹	Martino D...Defazio G	22890501	2012
513	Uveodermatologic lymphoma in two young related Portuguese water dogs. ⁶¹	Escanilla N...Pena T	22239173	2012
514	Demographic and clinical features of patients with blepharospasm in southern Taiwan: a university hospital-based study. ⁶¹	Hwang WJ	23196730	2012
515	Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience. ⁶¹	Aquino CC...Ferraz HB	22990720	2012
516	Desmoplastic trichoepithelioma: report of a unique periocular case. ⁶¹	Kirzhner M...Borodic G	22366669	2012
517	Botulinum toxin for the treatment of movement disorders. ⁶¹	Thenganatt MA...Fahn S	22661378	2012
518	Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. ⁶¹	Wabbels B...Roggenkamper P	22231846	2012
519	Isolated frontalis, corrugator and procerus dystonia: a blepharospasm variant. ⁶¹	Fabiani G...Teive HA	22899039	2012
520	Dementia with lewy bodies in meige syndrome. ⁶¹	Chan LK...Yu CS	22984651	2012
521	Application of botulinum toxin to clinical therapy: advances and cautions. ⁶¹	Levy NS...Lowenthal DT	22481607	2012
522	Current and future medical treatment in primary dystonia. ⁶¹	Delnooz CC...van de Warrenburg BP	22783371	2012
523	Blepharospasm in a patient with pontine capillary telangiectasia. ⁶¹	Gilbert AL...Horton JC	22082598	2012
524	A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: a new botulinum neurotoxin A. ⁶¹	Pagan FL...Harrison A	22405829	2012
525	Anatomical correlates of blepharospasm. ⁶¹	Horovitz SG...Hallett M	23210426	2012
526	Treatment of focal dystonia. ⁶¹	Batla A...Bhatia KP	22415705	2012
527	Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. ⁶¹	LeDoux MS...Zhao Y	22377579	2012
528	[Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin]. ⁶¹	Winterhoff J...Laskawi R	22669435	2012
529	Botulinum toxins in the treatment of primary focal dystonias. ⁶¹	Truong D	22336699	2012
530	Botulinum toxin clinic-based epidemiologic survey of adults with primary dystonia in East china. ⁶¹	Wang L...Chen J	24868406	2012
531	Gender differences in benign essential blepharospasm. ⁶¹	Lee MS...Harrison AR	22460669	2012
532	Blepharospasm and apraxia of eyelid opening associated with anti-Hu paraneoplastic antibodies: a case report. ⁶¹	Choe CH...Gausas RE	22264884	2012
533	Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. ⁶¹	Bentivoglio AR...Fasano A	21710123	2012
534	Effect of dietary zinc and phytase supplementation on botulinum toxin treatments. ⁶¹	Koshy JC...Soparkar CN	22453589	2012
535	Direct detection of Ehrlichia canis by PCR in the conjunctiva of a dog with bilateral anterior uveitis. ⁶¹	Walser-Reinhard L...Spiess B	22563611	2012
536	Conjunctivitis and ulcerative keratitis secondary to conjunctival plant foreign bodies in a herd of alpacas (Lama Pacos). ⁶¹	Fischer K...Hendrix D	22050866	2012
537	Acute primary canine herpesvirus-1 dendritic ulcerative keratitis in an adult dog. ⁶¹	Gervais KJ...Pizzirani S	22051326	2012
538	Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins. ⁶¹	Dressler D	22035051	2012
539	Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment. ⁶¹	Rana AQ...Shah R	22427299	2012
540	[Neurotaping: new therapeutic approach in essential blepharospasm]. ⁶¹	Dolz-Marco R...Diaz-Llopis M	22423659	2012
541	Resolution of blepharospasm after chronic subdural haematoma evacuation: A case report. ⁶¹	Velnar T...Bunc G	22327937	2012
542	Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs. ⁶¹	Sarchahi AA...Gholipour MA	22050700	2012
543	Eye symptoms in relatives of patients with primary adult-onset dystonia. ⁶¹	Defazio G...Berardelli A	22173654	2012
544	Quantification of macular carotenoids using autofluorescence imaging in patients with photosensitive migraine and benign essential blepharospasm. ⁶¹	Frandsen JE...Katz BJ	22332230	2012
545	Efficacy of zolpidem for dystonia: a study among different subtypes. ⁶¹	Miyazaki Y...Kaji R	22529836	2012
546	Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor. ⁶¹	Rana AQ...Khondker S	23075668	2012
547	Temporal discrimination thresholds in adult-onset primary torsion dystonia: an analysis by task type and by dystonia phenotype. ⁶¹	Bradley D...Hutchinson M	21656045	2012
548	Dystonia: phenomenology. ⁶¹	LeDoux MS	22166421	2012
549	A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. ⁶¹	Jimenez-Shahed J	22275842	2012
550	[Dystonia as a common status against a common belief]. ⁶¹	Mezaki T	23196518	2012
551	Pathophysiology of brainstem lesions due to overdrainage. ⁶¹	Antes S...Kiefer M	22116447	2012
552	Botulinum toxin injections for blepharospasm prior to ocular surgeries. ⁶¹	Okumus S...Gurler B	22654489	2012
553	[Essential blepharospasm : Practice-oriented therapy with botulinum toxin employing reduced treatment intervals]. ⁶¹	Wabbels B...Roggenkamper P	22130729	2012
554	The use of punctal plugs in children. ⁶¹	Mataftsi A...Nischal KK	22021004	2012
555	Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. ⁶¹	Kurlan R	22170944	2011
556	Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms. ⁶¹	Limotai N...Okun MS	21553081	2011
557	[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin]. ⁶¹	Yabiku MM...Cariello AJ	22331113	2011
558	Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. ⁶¹	Setthawatcharawanich S...Phabphal K	21431990	2011
559	Obsessive-compulsive symptoms in primary focal dystonia: a controlled study. ⁶¹	Barahona-Correa B...Xavier M	21830232	2011
560	Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. ⁶¹	Paus S...Abele M	21499724	2011
561	Can subcortical infarction cause apraxia of eyelid opening? ⁶¹	Lee SS...Lee HS	21778059	2011
562	Chronic (neuropathic) corneal pain and blepharospasm: five case reports. ⁶¹	Borsook D...Rosenthal P	21752546	2011
563	Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. ⁶¹	Mittal MK...Dimachkie M	22361625	2011
564	Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study. ⁶¹	Burbaud P...Joseph PA	21424611	2011
565	Successful treatment of distichiasis in a cat using transconjunctival electrocautery. ⁶¹	Reinstein SL...Komaromy AM	21923836	2011
566	Obsessive-compulsive symptoms among patients with blepharospasm and hemifacial spasm. ⁶¹	Fontenelle LF...Lauterbach EC	21762995	2011
567	Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. ⁶¹	Jog M...Simonyi S	21856572	2011
568	Acremonium keratomycosis in a cat. ⁶¹	Binder DR...Herring IP	21923833	2011
569	Corneal ulceration in a dog following exposure to the defensive spray of a walkingstick insect (Anisomorpha spp.). ⁶¹	Brutlag AG...Della Ripa MA	21827597	2011
570	Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study. ⁶¹	Martino D...Defazio G	21717508	2011
571	Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. ⁶¹	Defazio G...Berardelli A	21775731	2011
572	Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment. ⁶¹	Lerner V...Miodownik C	21519907	2011
573	Blepharospasm plus Cervical Dystonia with Predominant Anterocollis: A Distinctive Subphenotype of Segmental Craniocervical Dystonia? ⁶¹	Waln O...Ledoux MS	22229127	2011
574	Molecular analysis of Italian patients with congenital glaucoma. ⁶¹	Giuffre' I	21815720	2011
575	In the wink of an eye: nature and nurture in blepharospasm. ⁶¹	Jinnah HA...Hallett M	21775742	2011
576	Successful intravenous thrombolysis in a stroke patient with hemiballism. ⁶¹	Zidverc-Trajkovic J...Beslac-Bumbasirevic L	21712665	2011
577	Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia. ⁶¹	Dresel C...Haslinger B	21604301	2011
578	[Use of botulinum neurotoxin therapy]. ⁶¹	Mukai Y...Kaji R	21747148	2011
579	Uveodermatologic syndrome in a rat terrier. ⁶¹	Blackwood SE...Brooks DE	21730094	2011
580	[Clinical application of botulinum toxin]. ⁶¹	Mezaki T	21747149	2011
581	[Guideline of clinical practice for blepharospasm]. ⁶¹	Japanese Ophthalmological Society	21815492	2011
582	Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. ⁶¹	Jankovic J...Grafe S	21520284	2011
583	Use of collagen shields for treatment of chronic bilateral corneal ulcers in a pet rabbit. ⁶¹	Eshar D...Schoster JV	21726230	2011
584	Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. ⁶¹	Wabbels B...Roggenkamper P	21221669	2011
585	Tardive dyskinesia. ⁶¹	Aia PG...Factor SA	21365202	2011
586	[Sources of error in Goldmann applanation tonometry]. ⁶¹	Rufer F	21533609	2011
587	The left parietal lobe plays a role in the pathogenesis of blepharospasm? ⁶¹	Nociti V...Batocchi AP	21244581	2011
588	Impairment of the rubber hand illusion in focal hand dystonia. ⁶¹	Fiorio M...Classen J	21378099	2011
589	Loss of topographic specificity of LTD-like plasticity is a trait marker in focal dystonia. ⁶¹	Weise D...Classen J	21126584	2011
590	The effect of UV-blocking contact lenses as a therapy for canine chronic superficial keratitis. ⁶¹	Denk N...Reese S	21521443	2011
591	Botulinum toxin A (Dysport®): in dystonias and focal spasticity. ⁶¹	Keam SJ...Deeks ED	21668041	2011
592	Gray matter density increase in the primary sensorimotor cortex in long-term essential blepharospasm. ⁶¹	Suzuki Y...Ishii K	21310245	2011
593	A case with improvement of blepharospasm by zolpidem. ⁶¹	Sunwoo M...Choi SA	24868394	2011
594	Tardive Meige's syndrome associated with olanzapine. ⁶¹	Aggarwal A...Jiloha RC	21808480	2011
595	A 14-year-old girl who regained normal vision after bilateral visual impairment following hot water injury to the eyes. ⁶¹	Monsudi KF...Ayanniyi AA	23960925	2011
596	Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement. ⁶¹	Pate DO...Clode AB	21355805	2011
597	Clinical features of patients with blepharospasm: a report of 240 patients. ⁶¹	Peckham EL...Hallett M	20649903	2011
598	Visual signs and symptoms of progressive supranuclear palsy. ⁶¹	Armstrong RA	20629667	2011
599	Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. ⁶¹	Reese R...Krauss JK	21312284	2011
600	Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes. ⁶¹	Pirie CG...Pizzirani S	21366821	2011
601	Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. ⁶¹	Harrison AR...McLoon LK	21087967	2011
602	The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. ⁶¹	Schwingenschuh P...Bhatia KP	21321334	2011
603	Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. ⁶¹	Wabbels B...Roggenkamper P	21161715	2011
604	[Electronistagmographic characteristics of vestibular function and eyelids dystonia in patients with facial dyskinesias]. ⁶¹	Likhachev SA...Veevnik EV	21350413	2011
605	Adult-onset dystonia. ⁶¹	Evatt ML...Factor S	21496604	2011
606	Normal and abnormal lid function. ⁶¹	Rucker JC	21601075	2011
607	Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidence. ⁶¹	Linde M...Stovner LJ	21711257	2011
608	Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. ⁶¹	Park J...Harrison AR	21691580	2011
609	Effectiveness of unilateral pallidotomy for meige syndrome confirmed by motion analysis. ⁶¹	Valalik I...Csokay A	21494067	2011
610	[Neurologic indications of botulin in adults]. ⁶¹	Sotaniemi K	22238918	2011
611	[Applications of botulin]. ⁶¹	Lindberg L...Salmenkyla S	22238921	2011
612	Review and update of involuntary facial movement disorders presenting in the ophthalmological setting. ⁶¹	Ross AH...Malhotra R	21093885	2011
613	Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. ⁶¹	Wu CJ...Lian YJ	22194126	2011
614	Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation. ⁶¹	Emoto Y...Wakakura M	21753898	2011
615	Blepharospasm as an obsessive-compulsive phenomenon. ⁶¹	Jain M...Khandelwal A	21677211	2011
616	Positive Correlation between Severity of Blepharospasm and Thalamic Glucose Metabolism. ⁶¹	Murai H...Ishii K	22110436	2011
617	Risk and protective factors for spasmodic dysphonia: a case-control investigation. ⁶¹	Tanner K...Smith ME	20171836	2011
618	An unusual cause of dementia: essential diagnostic elements of corticobasal degeneration-a case report and review of the literature. ⁶¹	Mastrolilli F...Vernieri F	21785700	2011
619	Botulinum toxin in facial rejuvenation: an update. ⁶¹	Carruthers J...Carruthers A	21093750	2010
620	Risk of glaucoma among patients with benign essential blepharospasm. ⁶¹	Lee MS...Sloan FA	20724866	2010
621	A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm. ⁶¹		21068703	2010
622	Ophthaproblem. Can you identify this condition? Benign essential blepharospasm. ⁶¹	Gill HS...Noble J	21075996	2010
623	Treatments for neuro-ophthalmologic conditions. ⁶¹	Spencer BR...Digre KB	20816275	2010
624	An unusual cause of blepharospasm. ⁶¹	Sobri Muda A...Viswanathan S	24148636	2010
625	Associative stimulation of the supraorbital nerve fails to induce timing-specific plasticity in the human blink reflex. ⁶¹	Zeuner KE...Siebner HR	21049057	2010
626	Transcranial magnetic brain stimulation modulates blepharospasm: a randomized controlled study. ⁶¹	Kranz G...Hallett M	20956792	2010
627	Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm. ⁶¹	Cannon PS...Leatherbarrow B	20456439	2010
628	Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm. ⁶¹	Dias FM...Teixeira AL	26952832	2010
629	Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. ⁶¹	Saeliw P...Aui-aree N	20973324	2010
630	Eye pain in preschool children: diagnostic and prognostic significance. ⁶¹	Richards AL...Zobal-Ratner J	21035061	2010
631	Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm. ⁶¹	Gill HS...Kraft SP	21059510	2010
632	[Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia]. ⁶¹	Oliveira FC...Osaki MH	21225122	2010
633	Can methylphenidate objectively provide relief in patients with uncontrolled blepharospasm? A pilot study using surface electromyography. ⁶¹	Price KM...Woodward JA	20683274	2010
634	Venom ophthalmia caused by venoms of spitting elapid and other snakes: Report of ten cases with review of epidemiology, clinical features, pathophysiology and management. ⁶¹	Chu ER...Warrell DA	20331993	2010
635	[Essential blepharospasm: literature review]. ⁶¹	Nicoletti AG...Matayoshi S	21225137	2010
636	Botulinum toxin type A: Exploring new indications. ⁶¹	Brashear A	20967299	2010
637	Topical anesthesia in phacoemulsification. ⁶¹	Waheeb S	21120050	2010
638	Long-term follow-up of deep brain stimulation for Meige syndrome. ⁶¹	Lyons MK...Evidente VG	20672922	2010
639	Outcome of pallidal deep brain stimulation in meige syndrome. ⁶¹	Ghang JY...Ghang CG	20856662	2010
640	Treatment of benign essential blepharospasm with finasteride: a case report. ⁶¹	Bortolato M...Marrosu F	20386102	2010
641	The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome. ⁶¹	Bastola P...Shah DN	22610735	2010
642	Craniocervical dystonia: clinical and pathophysiological features. ⁶¹	Colosimo C...Berardelli A	20590803	2010
643	Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis. ⁶¹	Voon YC...Ibrahim NM	20629121	2010
644	Essential blepharospasm. ⁶¹	Coscarelli JM	20590421	2010
645	Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation. ⁶¹	Markaki E...Constantoyannis C	20061080	2010
646	Iatrogenic botulism after botulinum toxin type A injections. ⁶¹	Coban A...Parman Y	20150804	2010
647	Orbicularis oculi myo-osseous fixation: a new treatment for benign essential blepharospasm and blepharospasm associated with diffuse facial dystonia (meige syndrome). ⁶¹	Borodic GE	20507022	2010
648	Acute blepharospasm and torticollis associated with an ependymoma of the lateral ventricle. ⁶¹	Lambrecq V...Burbaud P	20201058	2010
649	Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. ⁶¹	Cillino S...Casuccio A	19648904	2010
650	Quality of sleep in primary focal dystonia: a case-control study. ⁶¹	Avanzino L...Abbruzzese G	20039936	2010
651	Blepharospasm and vitamin B12 deficiency. ⁶¹	Edvardsson B...Persson S	20508362	2010
652	The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. ⁶¹	Martino D...Defazio G	20108367	2010
653	Topical botulinum toxin. ⁶¹	Collins A...Nasir A	20725542	2010
654	Psychiatric disorders in adult-onset focal dystonia: a case-control study. ⁶¹	Fabbrini G...Berardelli A	20108377	2010
655	Curvularia keratomycosis in a dog. ⁶¹	Ben-Shlomo G...Brooks D	20447033	2010
656	Photophobia in essential blepharospasm--a positron emission tomographic study. ⁶¹	Emoto H...Ishii K	20014062	2010
657	Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm. ⁶¹	Conte A...Berardelli A	19968711	2010
658	Lower limb involvement in adult-onset primary dystonia: frequency and clinical features. ⁶¹	Martino D...Defazio G	19765051	2010
659	Neurotoxin injection for movement disorders. ⁶¹	Charles D...Gill CE	22810184	2010
660	Speech-induced blepharospasm. ⁶¹	Martino D...Defazio G	19779797	2010
661	Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®. ⁶¹	Frevert J	20698714	2010
662	[Pantogam active in the complex treatment of dystonic hyperkineses]. ⁶¹	Katunina EA...Gridiakin VI	21389940	2010
663	The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients. ⁶¹	Malhotra R...Cheek E	20148097	2010
664	Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. ⁶¹	Quagliato EM...Viana MA	20124784	2010
665	Novel THAP1 sequence variants in primary dystonia. ⁶¹	Xiao J...LeDoux MS	20083799	2010
666	[Modern therapy in blepharospasm]. ⁶¹	Beres A	20540373	2010
667	A family with a hereditary form of torsion dystonia from northern Sweden treated with bilateral pallidal deep brain stimulation. ⁶¹	Blomstedt P...Forsgren L	19890997	2009
668	Blepharospasm and the modulation of cortical excitability in primary and secondary motor areas. ⁶¹	Kranz G...Hallett M	19996078	2009
669	Craniocervical Dystonia Questionnaire (CDQ-24): validation and cross-cultural adaptation in Serbian patients. ⁶¹	Tepavcevic DK...Kostic VS	20102067	2009
670	Xeomin: an innovative new botulinum toxin type A. ⁶¹	Frevert J	20002741	2009
671	Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. ⁶¹	Jankovic J	20002742	2009
672	Botulism and vaccines for its prevention. ⁶¹	Smith LA	19837283	2009
673	Unilateral blepharospasm and blepharoptosis with bilateral vertical gaze palsy in thalamic hemorrhage. ⁶¹	Chauhan V...Thakur S	20329446	2009
674	An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. ⁶¹	Rubin M...Nestor M	19945005	2009
675	Use of botulinum A toxin (BOTOX) in different types of facial dystonia. ⁶¹	Shoaib KK...Khan MD	19889277	2009
676	Development of future indications for BOTOX. ⁶¹	Brin MF	19470342	2009
677	Botulinum toxin in facial rejuvenation: an update. ⁶¹	Carruthers J...Carruthers A	19850191	2009
678	Cognitive disturbances in primary blepharospasm. ⁶¹	Aleman GG...Micheli F	19705473	2009
679	Disease-oriented approach to botulinum toxin use. ⁶¹	Jankovic J	19073203	2009
680	Xeomin is free from complexing proteins. ⁶¹	Frevert J	19292989	2009
681	Primary ocular melioidosis due to a single genotype of Burkholderia pseudomallei in two cats from Arnhem Land in the Northern Territory of Australia. ⁶¹	Parkes HM...Malik R	19428280	2009
682	Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections. ⁶¹	Yomtoob DE...Harrison AR	19966651	2009
683	Effect of reading on surface electromyogram recordings in patients with blepharospasm. ⁶¹	Richard MJ...Woodward JA	19966652	2009
684	Acute effects of sulfur mustard injury--Munich experiences. ⁶¹	Kehe K...Zilker T	19482056	2009
685	Abnormalities induced in reciprocal inhibition between orbicularis oculi and levator palpebrae following peripheral facial palsy. ⁶¹	Pardal-Fernandez JM...Iniesta-Lopez I	19845102	2009
686	Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. ⁶¹	Yoon JS...Lee SY	19794937	2009
687	Meige syndrome: what's in a name? ⁶¹	LeDoux MS	19457699	2009
688	Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? ⁶¹	Lange O...Wohlfarth K	19620852	2009
689	[Botulinum toxin therapy for focal dystonia]. ⁶¹	Hahn K...Szupera Z	19581172	2009
690	[18q syndrome associated with blepharospasm]. ⁶¹	Cabo-Lopez I...Garcia-Ruiz PJ	19598144	2009
691	Upper lid orbicularis oculi muscle strip and sequential brow suspension with autologous fascia lata is beneficial for selected patients with essential blepharospasm. ⁶¹	Patil B...Foss AJ	18927593	2009
692	Feline entropion: a case series of 50 affected animals (2003-2008). ⁶¹	Williams DL...Kim JY	19604337	2009
693	Chlamydophila felis infection. ABCD guidelines on prevention and management. ⁶¹	Gruffydd-Jones T...Horzinek MC	19481040	2009
694	[Ocular motility disorders in a patient with Fabry's disease]. ⁶¹	Fiore B...Lanzl I	19499232	2009
695	FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. ⁶¹	Blackburn MK...Katz BJ	19410958	2009
696	Diagnostic exercise: epithelioid hemangiosarcoma mimicking metastatic prostatic neoplasia in a dog. ⁶¹	Shor S...Lohr CV	19176508	2009
697	[Hemifacial spasm]. ⁶¹	Krystkowiak P	19576481	2009
698	Unilateral blepharospasm as an early sign of cephalic tetanus. ⁶¹	Liu CY...Tsai CP	19243061	2009
699	Experience with long-term treatment with albumin-supplemented botulinum toxin type A. ⁶¹	Mohammadi B...Dengler R	19319477	2009
700	Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. ⁶¹	Bentivoglio AR...Albanese A	19384595	2009
701	Executive functioning in patients with blepharospasm in comparison with patients with hemifacial spasm. ⁶¹	Dias FM...Teixeira AL	19330202	2009
702	High-throughput mutational analysis of TOR1A in primary dystonia. ⁶¹	Xiao J...LeDoux MS	19284587	2009
703	High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference? ⁶¹	Boyle MH...Long JA	19300145	2009
704	Increase in the tactile catchment area of a sensory trick for alleviating blepharospasm following pallidal DBS. ⁶¹	Bain PG...Aziz TZ	19185017	2009
705	Quality of life in patients with focal dystonia. ⁶¹	Pekmezovic T...Kostic VS	18995953	2009
706	Relationship between various clinical outcome assessments in patients with blepharospasm. ⁶¹	Jankovic J...Comes G	19053054	2009
707	Acute laryngeal and bronchial obstruction after CS (o-chlorobenzylidenemalononitrile) gas inhalation. ⁶¹	Karaman E...Duman GU	18365225	2009
708	The Lanindar test: a method of evaluating patient suitability for cataract surgery using assisted topical anaesthesia. ⁶¹	Figueira EC...Stapleton F	18259208	2009
709	[Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia]. ⁶¹	Likhachev SA...Veevnik EV	19365387	2009
710	Browlifting as an alternative procedure for apraxia of eyelid opening. ⁶¹	Nicoletti AG...Matayoshi S	19273924	2009
711	Prevalence of primary focal or segmental dystonia in adults in the district of foggia, southern Italy: a service-based study. ⁶¹	Papantonio AM...Specchio LM	19556806	2009
712	Blink reflex recovery in central and peripherally originated movement disorders of the cranio-cervical area: a comparative study. ⁶¹	Yaman M...Kiziltan ME	19280796	2009
713	Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution. ⁶¹	Labelle AL...Breaux CB	19152598	2009
714	Controversy: botulinum toxin in pregnancy. ⁶¹	Paul M	20300363	2009
715	Decreased dopamine D receptor binding in essential blepharospasm. ⁶¹	Horie C...Ishii K	18540899	2009
716	Videonystagmography to assess eyelid dynamic disorders. ⁶¹	Casse G...Robert PY	19229740	2009
717	[Use of botulinum neurotoxin for spasticity]. ⁶¹	Mukai Y...Kaji R	19110753	2008
718	Keratoconjunctivitis sicca attributable to parasympathetic facial nerve dysfunction associated with hypothyroidism in a horse. ⁶¹	Schwarz BC...Nell B	19046036	2008
719	[Diagnosis and treatment of dystonia]. ⁶¹	Kaji R...Goto S	19198096	2008
720	[Ameliorating strabismus, preventing blepharospasm: botulinum toxin can do more than smooth wrinkles]. ⁶¹	Arand M	19189451	2008
721	Movement disorders in multiple sclerosis: Causal or coincidental association? ⁶¹	Nociti V...Batocchi AP	18768580	2008
722	Lower facial contouring with botulinum toxin type A. ⁶¹	Tartaro G...Itro A	19098563	2008
723	Dystonic frowning without blepharospasm. ⁶¹	Hirota N...Mezaki T	18316230	2008
724	Update on blepharospasm: report from the BEBRF International Workshop. ⁶¹	Hallett M...BEBRF International Workshop	18852443	2008
725	Patients with essential blepharospasm and glaucoma: case reports. ⁶¹	Nicoletti AG...Matayoshi S	19039478	2008
726	Ocular and multicentric lymphoma in a young racehorse. ⁶¹	Germann SE...Spiess BM	19046270	2008
727	Pallidal deep brain stimulation in the treatment of Meige syndrome. ⁶¹	Blomstedt P...Hariz MI	18336624	2008
728	Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection. ⁶¹	Casse G...Robert PY	18581129	2008
729	[Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A]. ⁶¹	Vogt T...Urban P	18551268	2008
730	Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia. ⁶¹	Obermann M...Maschke M	18557921	2008
731	Tactile temporal discrimination in patients with blepharospasm. ⁶¹	Fiorio M...Berardelli A	17986501	2008
732	Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. ⁶¹	Badarny S...Honigman S	18751631	2008
733	Ocular manifestations in a case of childhood cicatricial pemphigoid. ⁶¹	Iovine A...Magli A	18609489	2008
734	[Intraocular hemorrhage in a goat with thrombocytopenia and metastasis of an adenocarcinoma in the iris]. ⁶¹	Braun U...Spiess B	18714940	2008
735	Secondary acute anterior uveitis with hyphema in a purpose-bred kitten. ⁶¹	Sorrell MS...Fish RE	18702452	2008
736	[Botulinum toxin. Development for therapeutic purposes]. ⁶¹	Ceballos-Baumann A	18927957	2008
737	Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. ⁶¹	Simpson DM...Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology	18458230	2008
738	Long-term assessment of the risk of spread in primary late-onset focal dystonia. ⁶¹	Abbruzzese G...Defazio G	17635969	2008
739	Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases. ⁶¹	Lopez Valdes E...Bilbao-Calabuig R	18200601	2008
740	Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. ⁶¹	Forni GL...Marchese R	18383118	2008
741	Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. ⁶¹	Georgescu D...Anderson RL	18191096	2008
742	The use of botulinum toxin in head and face medicine: an interdisciplinary field. ⁶¹	Laskawi R	18331633	2008
743	Pain relief in patients receiving periocular botulinum toxin A. ⁶¹	Harrison AR...Lee MS	18356715	2008
744	Lamellar keratoplasty with a graft of lyophilized acellular porcine corneal stroma in the rabbit. ⁶¹	Lin XC...Jin Y	18302569	2008
745	Exacerbation of blepharospasm associated with craniocervical dystonia after placement of bilateral globus pallidus internus deep brain stimulator. ⁶¹	Vagefi MR...Anderson RL	18074391	2008
746	Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm. ⁶¹	Fabbrini G...Berardelli A	18217887	2008
747	Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. ⁶¹	Kymionis GD...Yoo SH	18216583	2008
748	Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. ⁶¹	Truong D...Dysport Benign Essential Blepharospasm Study Group	18325821	2008
749	[Functional neurology of blepharospasm]. ⁶¹	Leon-Sarmiento FE...Bayona-Prieto J	18786893	2008
750	Limbal stem cell transplantation: an evidence-based analysis. ⁶¹	Medical Advisory Secretariat	23074512	2008
751	Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. ⁶¹	Kenney C...Jankovic J	17558461	2008
752	[Mechanism of therapy effects by botulinum neurotoxin]. ⁶¹	Alajbegovic A...Resic H	18543757	2008
753	Drug-induced ocular disorders. ⁶¹	Li J...Tripathi BJ	18217789	2008
754	Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report. ⁶¹	Takahashi T...Wada Y	17987656	2008
755	The course of tardive dystonia in Afro Caribbean patients, a population-based study: the Curacao extrapyramidal syndromes study: VII. ⁶¹	van Harten PN...Van Os J	17936588	2008
756	Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics. ⁶¹	Cosmetic Ingredient Review Expert Panel	18830862	2008
757	Closely spaced stressful life events precede the onset of benign essential blepharospasm and hemifacial spasm. ⁶¹	Johnson LN...Hackley SA	18090560	2007
758	Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. ⁶¹	Ochudlo S...Opala G	17543569	2007
759	Hemifacial spasm: a neurosurgical perspective. ⁶¹	Kong DS...Park K	19096569	2007
760	Calcified tumours of the paranasal sinuses in three horses. ⁶¹	Schaaf KL...Lovell DK	17970850	2007
761	Actinomyces endophthalmitis and pneumonia in a dog. ⁶¹	Barnes LD...Grahn BH	18050796	2007
762	Community survey of primary dystonia in the city of Kolkata, India. ⁶¹	Das SK...Hazra A	17722044	2007
763	[What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?]. ⁶¹	Roggenkamper P	17726608	2007
764	What is new in the era of focal dystonia treatment? Botulinum injections and more. ⁶¹	Cetinkaya A...Brannan PA	17700237	2007
765	Electroconvulsive therapy and ocular dystonia. ⁶¹	Sharma A...Sorrell JH	17804995	2007
766	Severe, unilateral, unresponsive keratoconjunctivitis sicca in 16 juvenile Yorkshire Terriers. ⁶¹	Herrera HD...de Jalon JA	17760706	2007
767	Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control study. ⁶¹	Defazio G...Berardelli A	17578856	2007
768	Health-related quality of life in blepharospasm and hemifacial spasm. ⁶¹	Tan EK...Seah A	17698774	2007
769	Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment. ⁶¹	Alkin T...Ozerdem A	17537560	2007
770	Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. ⁶¹	Delmaire C...Lehericy S	17646630	2007
771	Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. ⁶¹	Suzuki Y...Ishii K	17325818	2007
772	Apraxia of lid opening. ⁶¹	Ugarte M...Teimory M	17576707	2007
773	Spread of primary dystonia in relation to initially affected region. ⁶¹	Svetel M...Kostic VS	17401742	2007
774	Botulinum toxin treatment for blepharospasm associated with myasthenia gravis. ⁶¹	Hara K...Tagawa A	17486596	2007
775	Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene. ⁶¹	Kim HT...Bhatia KP	17534980	2007
776	The "Indian turban trick": a novel sensory trick in blepharospasm. ⁶¹	Ragothaman M...Muthane UB	17486641	2007
777	Computer vision syndrome: a study of the knowledge, attitudes and practices in Indian ophthalmologists. ⁶¹	Bali J...Thakur BR	17595478	2007
778	Morphometric changes of sensorimotor structures in focal dystonia. ⁶¹	Obermann M...Maschke M	17443700	2007
779	Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. ⁶¹	Sheffield JK...Jankovic J	17563247	2007
780	Efficacy of intrapalpebral and intramuscular application of oxytetracycline in a natural outbreak of infectious bovine kertoconjunctivitis (IBK) in calves. ⁶¹	Starke A...Rehage J	17642322	2007
781	Venlafaxine and tardive blepharospasm: a case report. ⁶¹	Lee Y...Chang YY	17478026	2007
782	Botulinum toxin in the management of dystonia. ⁶¹	Cardona-Garcia OD...Molho ES	17445500	2007
783	Peripheral kynurenine metabolism in focal dystonia. ⁶¹	Hartai Z...Vecsei L	17504201	2007
784	Evaluation of the clinical efficacy of subconjunctival injection of clindamycin in the treatment of naturally occurring infectious bovine keratoconjunctivitis. ⁶¹	Senturk S...Ozel E	17445081	2007
785	A case of primary congenital glaucoma: a diagnostic dilemma. ⁶¹	Girgis NM...Frantz KA	17400138	2007
786	Use of chemical ablation with trichloroacetic acid to treat eyelid apocrine hidrocystomas in a cat. ⁶¹	Yang SH...Lin CT	17501654	2007
787	Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases. ⁶¹	Kanazawa M...Nishizawa M	17266083	2007
788	Modified Lundie loops improve apraxia of eyelid opening. ⁶¹	Ramasamy B...Noonan C	17414870	2007
789	Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm. ⁶¹	Martino D...Berardelli A	17260341	2007
790	Is there a place for placebo in management of psychogenic movement disorders? ⁶¹	Lim EC...Seet RC	17450268	2007
791	Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection. ⁶¹	Elibol O...Caglar Y	17413628	2007
792	Complications of botulinum toxin type A. ⁶¹	Carruthers J...Carruthers A	17317555	2007
793	Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. ⁶¹	Jost WH...Grafe S	17385940	2007
794	Asynchronous blepharospasm, facial and cervical dystonia, and bilateral asynchronous hemifacial spasm. ⁶¹	Katz BJ...McCann JD	17133455	2007
795	A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. ⁶¹	Rieder CR...Picon PD	17272968	2007
796	Auditory startle reaction in primary blepharospasm. ⁶¹	Muller J...Kofler M	17149731	2007
797	Graded full-thickness anterior blepharotomy for correction of upper eyelid retraction not associated with thyroid eye disease. ⁶¹	Demirci H...Elner VM	17237689	2007
798	Use of a dermal biopsy punch for removal of ectopic cilia in dogs: 19 cases. ⁶¹	D'Anna N...Guerriero A	17204131	2007
799	Clozapine-induced tardive dystonia (blepharospasm). ⁶¹	Duggal HS...Mendhekar DN	17308236	2007
800	Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy. ⁶¹	Wabbels B...Roggenkamper P	16874524	2007
801	Anatomy of the supraorbital region and the evaluation of it for the reconstruction of facial defects. ⁶¹	Erdogmus S...Govsa F	17251847	2007
802	The eyelid and its contribution to eye movements. ⁶¹	Helmchen C...Rambold H	17314482	2007
803	Double-clip technique in cataract surgery using topical anesthesia. ⁶¹	Arora A...Stevens JD	17189788	2007
804	[Wernicke's encephalopathy associated with chronic disulfiram intoxication]. ⁶¹	Charles V...Gille M	17151518	2006
805	Clinical value of botulinum toxin in neurological indications. ⁶¹	Ward AB...Berardelli A	17112346	2006
806	Dystonia in Parkinson's disease. ⁶¹	Tolosa E...Compta Y	17131231	2006
807	Paroxysmal torticollis and blepharospasm following bilateral cerebellar infarction. ⁶¹	O'Rourke K...Hutchinson M	17219037	2006
808	[Current status and prospects of medical therapy for dystonia]. ⁶¹	Osawa M	17432235	2006
809	Efficacy of botulinum toxin type a after topical anesthesia. ⁶¹	Sami MS...Hollier LH	17117100	2006
810	Bilateral upper eyelid ectropion associated with blepharospasm. ⁶¹	Koh S...Tano Y	17057180	2006
811	Tardive blepharospasm beginning after withdrawal of veralipride. ⁶¹	Alonso-Navarro H...Jimenez-Jimenez FJ	16960858	2006
812	Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey. ⁶¹	Cossu G...Contu P	16960861	2006
813	Controlling blepharospasm effect during applanation tonometry using the Volk SuperField Lid Lens Adapter. ⁶¹	Mohammed BR...Perry SR	17191193	2006
814	Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarction. ⁶¹	Sun CH...Huang TL	17095902	2006
815	Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. ⁶¹	Balali-Mood M...Hefazi M	17040211	2006
816	Botulinum toxin: clinical use. ⁶¹	Truong DD...Jost WH	16870487	2006
817	[Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm]. ⁶¹	Lasalvia CG...Kitadai SP	17187139	2006
818	Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993. ⁶¹	Fukuda H...Nakashima K	16755586	2006
819	Bilateral grey-matter increase in the putamen in primary blepharospasm. ⁶¹	Etgen T...Sander D	16690695	2006
820	Supramaximal doses of botulinum toxin for refractory blepharospasm. ⁶¹	Levy RL...Miller NR	16828511	2006
821	Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis. ⁶¹	Panegyres PK...Fallon M	16905752	2006
822	Relative risk of spread of symptoms among the focal onset primary dystonias. ⁶¹	Weiss EM...Perlmutter JS	16673404	2006
823	Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases. ⁶¹	Ortisi E...Collin JR	16531977	2006
824	Analysis of blink rate in patients with blepharospasm. ⁶¹	Bentivoglio AR...Fasano A	16622858	2006
825	Corneal ulceration associated with naturally occurring canine herpesvirus-1 infection in two adult dogs. ⁶¹	Ledbetter EC...Schatzberg SJ	16881829	2006
826	Hemifacial spasm: case report. ⁶¹	Jowi JO...Macharia MI	17089501	2006
827	The evaluation of light sensitivity in benign essential blepharospasm. ⁶¹	Adams WH...Katz BJ	16815254	2006
828	Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much? ⁶¹	Pang AL...O'Day J	16872340	2006
829	Prevalence of dystonia in Akit

Blepharospasm

Aliases & Classifications for Blepharospasm

MalaCards integrated aliases for Blepharospasm:

Classifications:

External Ids:

Summaries for Blepharospasm

Related Diseases for Blepharospasm

Diseases in the Blepharospasm family:

Diseases related to Blepharospasm via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Blepharospasm:

Symptoms & Phenotypes for Blepharospasm

UMLS symptoms related to Blepharospasm:

MGI Mouse Phenotypes related to Blepharospasm:

Drugs & Therapeutics for Blepharospasm

Drugs for Blepharospasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 71 / NDF-RT 50 :

Genetic Tests for Blepharospasm

Genetic tests related to Blepharospasm:

Anatomical Context for Blepharospasm

MalaCards organs/tissues related to Blepharospasm:

Publications for Blepharospasm

Articles related to Blepharospasm:

Inferred drug relations via UMLS ⁷¹ / NDF-RT ⁵⁰ :